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UNIVERSITY OF EDINBURGH
ABSTRACT OF THESIS (Regulation 7.9)
This thesis describes a study of nosocomial infection which was undertaken in the Intensive Care Unit, the
Hospital for Sick Children, Toronto, Canada and which reviewed prospectively 685 patients from July 1987 to
Febnrary 1988. The first aim of the study was to document the incidence of nosocomial infection by site
and clinical pathogen in this population and to report the use of a severity of illness score (PRISM) as a
predictor of the population at risk of acquiring infection. The second aim was to report the incidence of
both wcund and non-wound nosocomial infection in the post operative cardiac surgery patients with a focus
cn operative procedure and patient status at the tine of surgery. The third aim was to report the sensitivity
and specificity of a novel system of infection surveillance, recently introduced. The final aim was to
document seme adverse effects of nosocomial infection and to undertake a crude costing study of intravenous
antibiotic required for their treatment.
As an introduction, the relevant literature is reviewed and certain issues such as infection surveillance,
severity of illness scoring and criteria for infection are discussed in same detail. Study methodology is
presented and ethical issues are considered.
The study reports nosocomial infection rate of 7 infected patients per 100 patients admitted. As a percentage
of the total, the most prevalent pathogentic organisms are: ccagulase negative staphylococci (32%),
Pseudononas aeruginosa (23%), Candida species (20%) and Staphylococcus aureus (9%); the comonest sites of
infection are: blood stream (36%), skin/eye drdin site (22%); respiratory tract (16%); wound (15%) and
urinary tract (9%). Severity of the underlying illness on admission, as measured by the PRfi3*l scoring system,
predicts a population at risk of developing nosocomial infection. Patients with admission PREM scores of
>10 are significantly more likely to acquire infection that those with scores <10 (10.8% vs 3.6%, p < 0.001)
and this association holds through age, clinical speciality and length of stay. The sensitivity, specificity,
positive and negative predictive values of a PREM score > 10 are 75%, 53%, 11% and 97% respectively.
In post operative cardiac surgery patients non-wound infections account for 72% of the total nosocomial
infections. With regard to wound infection; the most prevalent pathogenic orgpnisns vary depending cn
whether surgery is closed ie.non bypass (Staph, aureus and coagulase negative staphylococci) or open ie.
bypass (coagulase negative staphylococci, P. aeruginosa, Candida species and Staph, aureus). Risk factors
for the acquisition of infection relate to specific operative procedures and to surgical technique particularly
the presence of an open sternotomy wound in the post operative period.
The systan of infection surveillance recently introduced in the PICU (the Infection Control Sentinel Sheet;
ICSS) compares favcurably with daily bedside examination of patients plus daily review of in-patient charts.
The ICSS, which requires enly 20 minutes of surveillance time per day, detects 87% of nosocanially infected
patients; 85% of infections at the three standard sites (blood, wound and urine); and 72% of infections at all
of the 11 sites surveyed.
Certain adverse effects of nosocomial infection are reported to occur in up to AC% of infected patients. A
crude costing study of intravenous antibiotic required for treatment of nosocomial infection suggests that the
miniraim cost was $Can 15,000 (approx £7,500).
In conclusion, following a resume of the results of the individual studies, areas, where future research
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THE PURPOSE OF THIS THESIS
THE PURPOSE OF THIS THESIS
It is essential to understand the epidemiology of
nosocomial infection in the Paediatric Intensive Care Unit
(PICU) and the underlying risk factors for its development,
in order to elaborate effective intervention strategies and
thereby reduce associated morbidity, mortality and patient
care expenditure. If this aim is to be realized, an
adequate paediatric data base must be available which
should be developed by undertaking specific studies in
infants and children rather than extrapolating from the
results of studies performed in adults.
To date, the majority of reports in the PICU-related
literature have solely addressed epidemic infection. Only
a very few studies of endemic infection have been published
and they have demonstrated considerable diversity in
certain aspects of study methodology namely criteria for
infection, definition of infection rates and infection
surveillance. There have also been differences with
respect to population characteristics; the severity of
their underlying illness, their patterns of length of stay
as well as efforts at prevention of infection. These
variations make it difficult to draw conclusions from the
results of individual studies and preclude comparisons of
results between institutions.
In the past, attempts have been made to associate certain
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underlying risk factors such as use of therapeutic devices,
clinical specialty, length of stay and age with the
subsequent acquisition of infection. Even though severity
of underlying illness is probably the single most important
factor determining the risk of acquiring infection in the
critically ill subjects, to date, its role has not been
defined in paediatric patients.
Commonly, cardiac surgical patients represent a significant
proportion of the PICU population. Surveys of nosocomial
infection in this group of patients have been confined to
wound infection only; the incidence of non-wound infection
has not been documented and infections have not been
stratified either by surgical procedure or patient status
at the time of surgery.
A novel system of nosocomial infection surveillance (the
Infection Control Sentinel Sheet) has been developed by the
Infection Control service for routine use in the Hospital
for Sick Children, Toronto. The system has been applied in
the PICU for more than a year; its specificity and
sensitivity require evaluation in this clinical area.
In the critically ill child to quantify objectively the
adverse effects of nosocomial infection is not a simple
matter since associations of infection with either
mortality or deterioration in clinical status or increased
length of stay/increased patient care expenditure are all
20
subject to the confounding effects of multiple uncontrolled
variables. To date, the adverse sequelae of nosocomial
infection have not been formally studied in critically ill
children and in the PICU the burden of illness resulting
from nosocomial infection has not been addressed.
The work for this thesis was carried out in the Intensive
Care Unit of the Hospital for Sick Children, Toronto,
Canada. The aims of the thesis were as follows
1. To define the PICU population using a validated
severity of illness scoring system (the PRISM
system) as well as traditional demographic data.
2. To undertake daily surveillance of this population
using bedside examination plus patient chart review
and systematically record the incidence of
nosocomial infection by site and organism, using
clearly defined criteria for infection.
3. To report the use of the PRISM score as a predictor
of the PICU population at risk of developing
nosocomial infection.
4. To report the incidence of wound and non-wound
nosocomial infection in the population of cardiac
surgical patients with a focus on severity of illness
and operative procedure.
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To document the occurence of selected adverse effects
of nosocomial infection in the PICU and undertake a
crude costing study of antibiotic required as
treatment for nosocomial infection.
To estimate the effectiveness and efficiency of a
novel system of infection surveillance currently in








In the following chapter I shall endeavour to provide an
overview of nosocomial infection in the Paediatric
Intensive Care Unit (PICU). The chapter opens with a
discussion of nosocomial infection, as it occurs in
paediatric patients in general, followed by a resume of the
risk factors and exposures particularly associated with the
acquisition of infection in the PICU. The related
literature is then reviewed, the formal studies of
nosocomial infection undertaken so far are discussed and
their limitations are identified. Thereafter, the adverse
sequelae of nosocomial infection, and the difficulties
associated with their measurement, are considered.
Finally, the features of an ideal system of nosocomial




For many years it has been recognized that individuals are
subject to increased risks of acquiring infection while in
hospital and this infection has been variously referred to
as cross infection, hospital-acquired infection and, more
recently, nosocomial infection.
More than half a century ago, the problem of cross
infection, and its control in children's hospitals, was the
subject of debate at medical gatherings and in the medical
press (Lancet 1933 [Leader]) (Glover 1934). In 1935, in
one of the Milroy lectures delivered before the Royal
College of Physicians in London, Dr. E. H. R. Harries,
Medical Superintendent of London County Council, presented
the results of an incidence study of cross infection,
undertaken between October, 1933 and September, 1934, in
the North Eastern Fever Hospital, London. During the study
period there were 221 episodes of cross infection in 5712
admissions - a rate of 3.8 infections per 100 patients
admitted. The commonest causes of cross infection were
scarlet fever, diphtheria, whooping cough, chickenpox,
measles and rubella although other infections such as
impetigo, Sonne dysentery, otitis media and ringworm were
observed. Souces of infection were classified as one of
three - external to the hospital; within the hospital but
external to the wards and; within the wards namely children
inadvertently admitted in the incubation or prodromal
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period of an acute infective condition or else unrecognized
carriers among patients, staff or visitors. Dr Harries was
fully aware of the undesirable sequelae of cross infection
which he claimed was "the bane of staffs of children's and
fever hospitals." There follows a short extract from his
dissertation:
"Upon the consequences of extraneous infection it is
unnecessary to dwell. They may be perilous to the
individual child; they are always, in some degree,
detrimental to the hospital. Long detention,
especially if the cause be some superimposed
infective process, may result in that complex of
physical and psychical deterioration known as
hospitalism.
From the administrative standpoint, if wards are
encumbered by long stay patients or closed to new
ones, the machinery of admission and discharge breaks
down. The overhead charges remaining undiminished,
the average cost of the patient treated rises.
Equally important, the reputation of the individual
institution or of institutions of its particular
type inevitably, if insensibly, suffers."
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The ensuing fifty years have witnessed a fundamental change
in the role of the children's hospital. Today, hospital
admission for the management of the acute infections of
childhood is seldom required and the 'fever hospital' has
become obsolete. Meanwhile, advances in medical technology
have produced a requirement for highly specialized forms of
patient care and 'new' clinical disciplines such as
neonatal and paediatric intensive care medicine have
evolved. Simultaneously over the last twenty years,
enormous progress has been made in the clinical discipline
of infectious diseases, which has been matched by
developments in sundry laboratory specialties such as
26
immunology and pharmacology. The human immune system and
the pathophysiology of processes of infection are now well
understood and, currently, physicians are aided by a
battery of sophisticated diagnostic and therapeutic
techniques. Immunization schedules offer protection
against a variety of organisms and research continuous
unabated in search of new vaccines particularly those
effective against viral infection. With regard to
pharmacology; the last decade has seen a veritable
explosion in the number of antibacterial, antiviral and
antifungal drugs available for therapeutic use. Meanwhile,
newly developed agents which act through manipulation of
the immune system, for example monoclonal antibody, are
showing promise.
Certainly, from the infectious diseases standpoint, the
latter half of this century has seen some spectacular
advances. Nonetheless, it is true to say that, at the
present time, nosocomial infection generates as much
concern in children's hospitals as it did fifty years ago.
The nosocomial infection rate for children in general
paediatric wards (expressed as the number of infections per
100 patients admitted) is estimated to be between 2% and 5%
(Wenzel 1976a) (Gardner 1972) (MMWR 1984) (Donowitz 1986b)
(Roy 1962) (Cooper 1970) (Welliver 1984) (Exon 1976)
(McNamara 1967). For additional information the reader is
referred to Jarvis' excellent review: 'Epidemiology of
nosocomial infections in pediatric patients' (Jarvis 1987),
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in which he combines data from published reports between
January 1970 and April 1986, with data from the Centers for
Disease Control's National Nosocomial Infections
Surveillance (NNIS) System (Jarvis 1983). (NNIS was
established in 1 970 and is the only continuous national
source of data on nosocomial infections in the United
States). Ford-Jones (1987) also addresses the special
problems of nosocomial infection in paediatric patients in
Prevention and Control of nosocomial Infections.
With further regard to nosocomial infection in children,
two significant statements can be made. Firstly, in recent
years it has become clear that within any hospital it is
critical care units which constitute the largest
identifiable source of infection (Donowitz 1982) (Caplan
1981). Nosocomial infection rates in these units may be in
excess of 20% (Wenzel 1976a) (Daschner 1982) (Kollish 1982)
and critical care unit patients have nosocomial infection
rates that are at least two to five times higher than those
in the general wards. (Donowitz 1982) (Chandrasekar 1986)
(Daschner 1982) (Massanari 1986) (Wenzel 1983). Patients
in intensive care units are particularly vulnerable to
primary bacteraemias, pneumonias and intra-abdominal
infections. Infection is the most frequent cause of death
- directly or indirectly - in patients who survive major
trauma or full thickness burns and is the most common
identified cause of multiple-organ failure. (Fry 1980)
(Pin 1983) (Marshall 1983).
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Secondly, as a general statement, the severity of illness
of hospitalized infants and children is increasing,
reflecting advances in technology and new approaches to
patient care. For example: techniques such as organ
transplantation and cytotoxic therapy produce large numbers
of hospitalized, immuno-compromised patients; extremely
complex cardiac surgical procedures are commonly performed
on high risk patients - in modern day surgical management
there are several indications for definitive cardiac
surgery in the first few days or weeks of life, for
example, the arterial switch procedure (Jatene 1976). Not
surprisingly, the last decade has seen a significant
increase in both the number and complexity of Paediatric
Intensive Care Units (PICUs) designed to deliver optimal
care to critically ill children and currently paediatric
intensive care medicine is a rapidly developing field.
It is essential to understand the epidemiology of
nosocomial infection in the PICU. Awareness of features
such as the origin of infection, outcome status and the
predominant sites and pathogens implicated may assist
institutions in developing effective intervention
strategies and reducing PICU related morbidity, mortality
and financial cost. A better appreciation of the risk
factors which predispose to infection may guide allocation
of resources in infection control and focus research
efforts. Furthermore, data from individual centres provide
a yard stick against which other hospitals may gauge their
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own infection rates for quality assurance purposes. To
achieve these aims, an adequate paedatric data base must be
developed and to do so specific studies must be undertaken
in infants and children rather than extrapolating from the
results of studies performed in adults or neonates.
So far, nosocomial infection in the PICU has been described
relatively infrequently hence very little by way of a data
base exists. In the literature only four formal studies of
endemic infection have been published. (Welliver 1984)
(Donowitz 1986b) (Brown 1987) (Milliken 1988) and in these
reports infection rates range from 2.5 infections per 100
patients admitted. (Milliken 1988) to 13 infections per
100 patients admitted. (Donowitz 1986b). Studies have
displayed considerable diversity in methodology and
consequently the varying incidences of infection and the
diverse proportional frequencies of infection by site and
pathogen are somewhat difficult to interpret.
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1 .2 RISK FACTORS ASSOCIATED WITH NOSOCOMIAL INFECTION IN
THE PICU
Patients admitted to the PICU are recognized to have an
increased risk of acquiring infection for many reasons.
(Holzman 1981) (Welliver 1984). Infections can occur in
almost every organ system and are almost exclusively
associated with some type of invasive monitoring or life-
support system. Disease processes may compromise host
defences as in cases of malignancy or burns, while
cellular immunity may be depressed in the patient whose
nutrition is less than optimal. (Edelman 1973) (Scrimshaw
1970). In neonates the immune system may be immature with
deficits in both the mobility and the bactericidal activity
of poly-morphonuclear leucocytes, particularly during
stress. (Klein 1977) (US DHEW Publication 1975) (Yu 1974).
Children under two years of age have difficulty responding
to polysaccharide antigen (Anderson 1977) (Cowan 1978)
(Peltola 1977) and are particularly susceptible to
infection with encapsulated organisms. This age group is
also vulnerable to infection with viruses and it is
noteworthy that both epidemiological and experimental
evidence support the hypothesis that primary viral
infection increases host susceptibility to secondary
bacterial, fungal and protozoal infection. (Mills 1984).
Multiple operations and invasive procedures, both
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therapeutic and diagnostic, may disrupt the integument or
other host defences. Tracheal intubation provides a
conduit which bypasses the normal host defence mechanisms
of the upper airway, interferes with ciliary function and
permits the passage of organisms from the supraglottic
flora directly down into the trachea. Colonization of the
airway occurs in virtually all patients in whom an
artificial airway has been in place for more than 72 hours
(Boysen 1979) though its significance is controversial. It
has been suggested that most cases of nosocomial pneumonia
are caused by aspiration of oral, pharyngeal or gastric
contents (Clenenden 1985) and that such aspiration occurs
in 70% to 80% of intubated neonates and children in whom
the use of uncuffed endotracheal tubes is indicated.
(Browning 1983) (Goodwin 1985).
Several reports have described a concordance between the
bacteria found in stomach/nasopharyngeal contents, and
those recovered from the trachea. (Atherton 1978) (de
Moulin 1982) (Hillman 1982) (Swift 1984). It is assumed
that organisms appear in the stomach contents by
retrograde spread from the intestine, though it is possible
that organisms from the mouth pass through the nasopharynx
and are swallowed to join gastric contents. Also, it
should be noted that retrograde colonization of the pharynx
from the stomach is an important, alternative route of
colonization. (Goularte 1986). Once in the stomach, the
survival of organisms is encouraged by the use of antacids
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and H2 receptor antagonists which increase gastric pH. The
stomach is normally sterile at an acid pH of 1 due to the
potent bactericidal activity of hydrochloric acid. (Garrod
1939). Gastric colonization with gram negative bacilli may
increase from zero at an acid pH of 1 to more than 100
million/mL at a pH of 6. (Donowitz 1986c) (Daschner 1988)
(Goularte 1986).
Purulent otitis media and sinusitis are associated with
mechanical ventilation, especially when a nasotracheal or
nasogastric tube is present. Otitis media, which is
usually preceded by middle ear effusion, has been described
in PICU patients (Persico 1985). Sinusitis, which is
usually preceded by purulent nasal discharge has been
reported in adult ICU patients (Deutschman 1986) (Kronberg
1 985) but, to date, no cases have been described in the
PICU.
Urethral catheters predispose to nosocomial infection, as
a result of contamination of the catheter or drainage
system by the hands of nursing and medical personnel
(Schaberg 1976). Up to one third of catheterised children
may develop urinary tract infection. (Causey 1981). The
risk of infection following a single in and out bladder
catheterization is estimated to be between 1% and 2% .
(Kunin 1966).
Invasive monitoring of intracranial pressure (ICP) is
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indicated in the management of several disease states.
(Moss 1979) (Rosner 1976). Central nervous system
infection has been shown to occur in up to 27% of patients
who have ICP monitoring devices (Mayhall 1984) though in
children, the risk of infection has been reported to
decrease after the sixth day of ICP monitoring. (Ranter
1 985) .
Colonization of vascular catheters and needles, sited both
intravenously and intra-arterially, constitutes another
serious source of nosocomial infection, commonly with
organisms of skin flora (Maki 1973) (Crossley 1972) (Peter
1972) (Collins 1968) (Fuchs 1971) (Band 1979) (Adams
1980). The risk of colonization increases with duration of
catheter use, method of catheter introduction, and type of
catheter material used. Polyethylene catheters and steel
needles tend to have a lower risk of colonization than
plastic catheters, and the incidence of colonization in
plastic catheters increases dramatically after 48 hours of
placement. (Maki 1973). Colonization of central venous
catheters and associated sepsis occurs in up to 27% of
adult patients and correlates with duration of placement
and the use of catheters for blood withdrawal. Candida and
other fungi may be responsible for more than half of these
infective episodes. (Maki 1973).
The risk of infection is greatest with pulmonary artery
flotation (Swan-Ganz) catheters because of the need to
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repeatedly withdraw blood samples and inject saline
solution for determination of cardiac output. Studies have
demonstrated that approximately one third of pulmonary
artery catheter tips were colonized at the time of removal,
though actual sepsis related to this occurred much less
frequently (2 out of 92 patients). (Elliott 1979) (Luc
1979). Septic endocarditis (due to staphylococcus aureus)
and aseptic vegetative endocarditis have been reported,
rarely, as complications of Swan-Ganz catheter use.
(Greene 1973, 1975) (Pace 1975).
In the PICU, the risk of procedure-related infections is
further increased by the fact that life-saving
interventions may be performed in an emergency situation
with compromise of the usual aseptic technique. Other risk
factors for infection may be identified: these patients
are exposed to large numbers of hospital personnel; they
reside in what is frequently the most crowded location
within the institution and they often have prolonged stays.
Intensive antiobiotic therapy, used in most critical care
units, distorts patients' microflora and fosters
colonization - and ultimately, infection with multiply
resistant organisms and with yeasts such as Candida.
(Finland 1970) (Pollack 1972) (Weinstein 1980, 1986)
(Sanders 1983) (McGowan 1983).
Infants and children in the PICU are critically ill and it
is suspected that in such patients the severity of
35
underlying illness is probably the single most important
factor determining the risk of acquiring infection and its
outcome. To date, studies investigating the role of
severity of illness as a risk factor for nosocomial
infection have been confined to critically ill adults and
neonates. Results have been somewhat variable.
In 1 978 Britt et al carried out a prospective study in
adult medical patients and determined that the severity of
underlying disease at the time of admission indicated
patients at unusual risk of nosocomial infection. These
workers used the system of severity of illness scoring
devised by McCabe and Jackson in 1962 (section 2.3.1) which
defined underlying illness as either "fatal", "ultimately
fatal" or "non fatal". The nosocomial infection rate was
23.6% in patients with fatal underlying disease, 9.6% in
those with ultimately fatal disease and 2.1% in those with
non fatal disease.
More recently Craven et al (1983) prospectively studied
over 1,300 adult medical and surgical ICU patients using
the APACHE 1 score (section 2.3.6) to define severity of
illness. This group of workers identified 23 variables
which were univariately associated with the development of
nosocomial infection (and which included severity of
illness score). The technique of stepwise logistic
regression analysis was then implemented to adjust for the
confounding effect of different variables. Following this
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manoeuvre, severity of illness score did not remain
significant as a predictor of nosocomial infection though
invasive devices did remain significant. Goldmann (1983)
suggested that invasive devices were at least as important
as underlying disease severity in determining
susceptibility to infection in neonates though studies in
the NICU are somewhat problematic since no accurate,
reproducible system exists for scoring severity of illness
in neonates. It should be noted that the use of invasive
devices may in fact be a marker for patients with more
severe underlying disease.
With regard to the PICUj nosocomial infections have been
analyzed most frequently in terms of clinical specialty
(Brown 1987), (Donowitz 1986b) (Welliver 1984) and, to a
lesser extent, therapeutic interventions and devices.
(Milliken 1988). In paediatric patients severity of
illness has not been measured and the role of severity of
illness as a risk factor for the development of nosocomial
infection has not been defined. To control for severity of
illness in the critically ill child requires quantitative
and unbiased methods which, to be practicable, must be
sufficiently easy to apply that dozens of admissions per
month can be scored. Two systems for quantifying severity
of illness in PICU patients have been validated - the
Physiologic Stability Index (PSI) (Yeh 1984) (Pollack
1987a), and its modification the Paediatric Risk of
37
Mortality (PRISM) (Pollack 1988). Severity of illness
scoring is reviewed more extensively in Chapter 2.3.
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1.3 REPORTED INCIDENCE OF NOSOCOMIAL INFECTION IN THE PICU
Nosocomial infection in the PICU has been addressed
infrequently and one reason for this may be the relatively
small number of specialized PICUs available for study. In
comparison, nosocomial infection in the Neonatal Intensive
Care Unit (NICU) has been well described, (Hemming 1976)
(Goldmann 1981a, 1981b) (Daschner 1 983) (Hoogkamp-Korstanje
1982) (Brown 1985) (Jarvis 1987) (Maguire 1981) (LaGamma
1983) (Hall 1979) (Johnson 1984) (Munson 1982) (Baley 1984)
(Anday 1 985) and on occasion data from the NICU has been
presented as PICU data (Massanari 1986). Likewise, there
is a large pool of information relating to nosocomial
infection in adult Intensive Care Units (Wenzel 1983)
(Donowitz 1982) (Chandrasekar 1986) (Brown 1985) (Daschner
1982) (Northey 1974) (Preston 1981) (Caplan 1979) (Thorp
1979). Unfortunately, inferences concerning the PICU
cannot be made from any of these data since it appears that
infections acquired in these critical care areas differ
substantially from infections acquired in the PICU in their
incidence, character and morbidity (Jarvis 1983).
Pathogens which cause nosocomial infections may be either
endogenous or exogenous. Endogenous pathogens are
organisms which are part of the normal flora of patients
and which under a variety of conditions, such as alteration
of the host's physical, immunologic or microbiologic
barriers, invade the host and become pathogenic.
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Exogenous pathogens are organisms which are acquired from
the external environment such as the PICU surroundings or
from exposures e.g. invasive devices, clinical personnel.
In the main, nosocomial infection is transmitted by three
routes. Transmission by common vehicles, such as water or
compressed air supply (Bjerring 1987), may occur, although
infrequently, and is usually confined to outbreaks.
Airborne transmission, especially by droplets, is more
common and includes transmission of viral infections. By
far, the commonest route of transmission of nosocomial
infection involves direct contact. Transmission via
contact with contaminated medical equipment may occur and
may involve urine collection receptacles (Schaberg 1976)
(Rutala 1981); respiratory therapy equipment (Arnow 1982)
(Gervich 1985) (Mehtar 1986); chamber domes or transducers
used for haemodynamic monitoring (Weinstein 1976) (Donowitz
1979) (Pien 1986); dialysis machines (Favero 1974)
(Berkelman 1982); or fibre-optic endoscopes (Schliessler
1980) and bronchoscopes (Webb 1975). However, the single
most important route of infection involves contact with the
hands of critical care unit staff, and handwashing has been
repeatedly described as the major means of its
interruption. (Donowitz 1987) (Mortimer 1962) (Albert
1981) (Steere 1975) (Larson 1988) (Reybrouck 1983). It is
emphasized that the hands of personnel serve not only as a
passive vehicle for the nosocomial transmission of
organisms, but may actually constitute a reservoir for
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their active multiplication. (Knittle 1975).
Nosocomial infections may be divided, somewhat arbitrarily,
into epidemic infections, endemic infections, pseudo-
infections and deliberate infections; to date it is
epidemic nosocomial disease which has been most commonly
reported. An epidemic is defined as 'an unusual,
statistically significant increase in the incidence of a
particular disease, usually occurring during a brief
interval in a single patient population, and often due to
a single microbial strain'. The critical care unit is a
particularly favourable environment for the occurrence of
epidemic nosocomial infection - particularly with
antibiotic resistant pathogens. (Wenzel 1983) (Maki
1981). The somewhat diverse nature of epidemic infection
in the PICU is illustrated by the following review of some
cases selected from the literature. In addition the
interesting, but rather uncommon, entities of pseudo-
infection and deliberate infection will be considered.
In 1984 Gardner observed colonization of single dose vials
of 0.45% saline (used for tracheal irrigation) with the
organism Pseudomonas pickettii and reported a colonization
rate of 31% during a three week period. In 1972 Morehead
documented the epidemiology of epidemic pseudomonas
infection in the PICU of the Children's Medical Centre,
Dallas and in 1983, in the same unit, Anderson described an
outbreak of infection with gentamicin resistant
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Enterobacter cloacae. Hilton (1983) described a cluster of
10 eye infections which occurred in a mixed group of
paediatric and adult intensive care unit patients, and
which were due to dispersion of bacteria during suction of
endotracheal tubes.
Bacteria and viruses may contaminate both blood products
and medical equipment. A case of Serratia marcescens
septic shock has been described in a ten year old PICU
patient following transfusion with infected platelets.
(Van Lierde 1985). Meanwhile, Fisher in 1981 and Noble in
1984 described clusters of bacteraemia due to contamination
of pressure transducers with Pseudomonas maltophilia.
Sporadic nosocomial viral disease in the PICU has been
reported by Krasinski (1985) who described upper
respiratory tract infection with particular reference to
Respiratory Syncytial Virus (RSV), and by Adams (1981) who
described herpes simplex infection affecting both patients
and nursing staff in a PICU.
Pseudobacteraemia has been demonstrated most commonly in
patients undergoing coagulation studies. Citrated
anticoagulant tubes have been shown to be contaminated with
both Pseudomonas fluorescens (Simor 1985) and with
Ewingella americana (Anderson 1985). When blood culture
and coagulation studies are performed simultaneously,
innoculation of the coagulation tube first (because it
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requires a precise amount of blood) may result in
contamination of the blood culture bottle and a spurious
diagnosis of bacteraemia. While pseudoinfections
originating in this manner are not unique to paediatric
patients, they may occur more frequently in this group
because of technical difficulties associated with blood
sampling.
Factitious illness in children, which has been induced by
adults, is a recognised entity, albeit one which is
reported infrequently. Polle syndrome has been suggested
as the preferred term for this child abuse variant of
Munchausen syndrome (also known as Munchausen by proxy).
Deliberate infection of hospitalized children (usually by
the mother) has been reported by Kohl in 1978, by Pickering
in 1981, by Kodge in 1 982 and by Liston in 1 983. In
clinical presentation cases resemble organic illness
occurring in association with polymicrobial bacteraemia.
However, despite extensive investigation no underlying
disease can be substantiated. To date no cases of this
condition have been reported in the PICU.
Footnote
Polle, who died at the age of one year, was the sole son of
Baron Von Munchausen. It is thought that the Baron may
have contributed to the child's early demise. (Burman
1 977) .
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It may be concluded that sporadic nosocomial disease has
been fairly well described and, indeed, most of our
understanding of nosocomial infection in the PICU is based
on studies of epidemics. It is apparent however, from
clinical practice, that the majority of nosocomial
infections occurring in this area are endemic in nature and
have no single or predominant cause. Despite this fact the
current literature contains reports from only four PICUs in
which the epidemiology of endemic nosocomial infection has
been systematically studied; these are summarised in Table
1 . Each study wi11 be reviewed with particular reference
to the estimated nosocomial infection rate and the observed
distribution of infections by site, pathogen and clinical
speciality.
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Table 1 Reported PICU Nosocomial Infection Ratios.












































* number of infections per 100 patients admitted or
discharged.
a all PICU patients
b patients remaining in PICU for 72 hours or more.
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In Buffalo Children's Hospital, Welliver studied the
epidemiology of nosocomial infection occurring throughout
the hospital including the PICU. The study expressed the
incidence of nosocomial infection as "attack rates" (number
of infections / 100 patients discharged), and recorded a
rate of 11 % in the 18 bedded PICU over a 1 year period
(1980 - 1981). No information was available with regard to
the distribution of PICU infection by site, clinical
speciality or pathogen. (Welliver 1984).
Brown et al in Baystate Medical Centre Massachusetts
expressed the incidence of nosocomial infection as an
infection rate (number of infections/number of ICU
admissions x 100) and reported a PICU acquired infection
rate of 6% in 965 children admitted to their six bedded
PICU during a two year period (1 982-1 984). This study
differed slightly from the others since it described all
infections i.e. community acquired and PICU acquired.
Staph, aureus accounted for 20% of infections, Klebsiella-
Enterobacter-Serratia for 18.3% of infections and E.Coli
for 15% of infections. There was no information regarding
the distribution by site or clinical speciality of those
infections specifically acquired in the PICU, though this
information was available with respect to the total number
of infections (PICU acquired plus community acquired).
(Brown 1987).
Donowitz in the University of Virginia, expressed the
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incidence of nosocomial infection as an infection rate
(number of infections/100 patients admitted) and reported
a rate of 13.7% during a 1 year period (1982-1983) in a 6
bedded PICU. The clinical specialities with the highest
infection rates were paediatric surgery (18.6% of
infections), thoracic/cardiovascular surgery (15.5% of
infections) and plastic surgery (13.2% of infections).
Site specific infection rates, expressed as a percentage of
total infections were detailed for: lung infection (21% of
infections), urinary tract infection (15%), postoperative
wound infection (10%) and blood stream infection (8%).
Specific pathogens were identified for bloodstream
infections only; the organisms identified most frequently
were Staph. epidermidis, Staph. aureus, Serratia
liquifaciens, and Escherichia Coli. (Donowitz 1986b).
In the Hospital for Sick Children, Toronto, Milliken et al
reviewed nosocomial infections occurring in 3,220 PICU
patients over a period of 30 months (1983-1985). This
group expressed the incidence of nosocomial infection as a
nosocomial infection ratio (number of patients acquiring
one or more infections divided by the total number of
patients admitted x 100). They reported infection ratios
of 2.6% for all patients admitted to the PICU and 6.1% for
those patients who remained in the PICU for a minimum of 72
hours. The most frequent sites of infection were, in
descending order:- bloodstream (40% of infections), lower
respiratory tract (15% of infections), gastrointestinal and
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urinary tract, skin and eye, post operative wound and upper
respiratory tract, peritoneal fluid. Clinical speciality
specific nosocomial infection ratios were, in descending
order:- neurosurgery (13.1% of infections) paediatric
surgery (11.2%), neurology (9.1%), renal (7.4%), ENT
(5.8%), general paediatrics (5.7%), cardiovascular surgery
(4.7%), plastic surgery (3.6%). The most common pathogens
isolated were gram positive cocci (42% of infections) with
coagulase-negative isolates accounting for 22% of
infections. Pseudomonas aeruginosa was the second most
common bacterial isolate causing nearly 20% of infections.
The relative frequency of virus infection was low (5.7% of
infections). (Milliken 1988).
It is noteworthy that, during their respective periods of
study, no institution observed an epidemic of infection
arising within the PICU and no occurrences of pseudo-
infection or deliberate infection were reported.
In the multidisciplinary PICU, patients from the cardiac
surgery service frequently constitute a significant
proportion of the patient population. Our own experience
is that some 40% of admissions are postoperative cardiac
surgery patients. Nonetheless, the epidemiology of
nosocomial infection in this particular group has been
poorly documented and to date studies have reported the
incidence of wound infection only.
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During a 12 month study period involving 6,775 procedures,
Edwards (1983) identified 9 children (0.1%) with median
sternotomy wound infections which included 3 children with
mediastinitis. Elsewhere, Culliford et al identified wound
infections in 0.4% of 227 children undergoing median
sternotomy, though patients with mediastinitis were not
specifically identified (Culliford 1976). To date no study
has stratified cardiac wound infection by operative
procedure or by the status of the patient at the time of
surgery. Furthermore, despite the increasing use of
complex, invasive monitoring devices, the incidence of non-
wound nosocomial infections in paediatric cardiac surgical
patients has not been documented.
1.4 LIMITATIONS OF PREVIOUS STUDIES OF NOSOCOMIAL INFECTION
IN THE PICU
Formal studies of endemic nosocomial infection, so far
undertaken in the PICU, have certain limitations which
merit further discussion. The studies present diversity in
both purpose and method and at times precise details of
methodology are not made available. These differences
limit the ability to make generalizations from results of
individual studies and also hamper comparisons of results
either between institutions or within the same institution
over time. The methodologic areas where there have been
substantial differences include: definitions of rates of
infection, criteria for infection, and methods of
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surveillance (case finding). Studies also differ with
respect to the characteristics of the population under
review - the severity of their underlying disease;
patterns of length of stay and efforts at prevention of
infection. All of these features may change over time and
geographic setting.
At this juncture, I do not intend to discuss particular
issues of methodology further but Chaper 2 is devoted to
detailed review of certain aspects of study namely
surveillance of infection, criteria for infection,
definition of rates of infection and severity of illness
scoring.
1.5 ADVERSE SEQUELAE OF NOSOCOMIAL INFECTION IN THE PICU
When one considers the adverse effects of nosocomial
infection ideally, all outcomes should be measured: death,
disease, disability, discomfort and dissatisfaction. Every
aspect of patient well being, physical, social and
emotional, should be considered as well as the attributable
cost of infection to patients, parents and health care
systems. There are no reports from paediatric intensive
care units which describe the adverse sequelae of
nosocomial infection and it is unclear what 'burden of
illness' nosocomial infection creates in this clinical
environment. To establish a causal association between
nosocomial infection and a particular adverse outcome
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presents formidable difficulties because of the confounding
effects of multiple uncontrolled variables. I shall now
review certain statistical issues which may complicate the
analysis of multiple variables in hospital epidemiology
(namely confounders and effect modifiers) and the various
techniques which have evolved to offset them.
1.5.1 Statistical Issues
1.5.1.1 Confounders and effect modifiers
Any study which involves epidemiological comparisons has
two primary variables - an exposure and an outcome. A
third variable, which is neither the exposure nor the
outcome, can distort the apparent effect of the exposure in
determining the outcome. Several factors or determinants
acting jointly are almost invariably responsible for any
single outcome in hospital epidemiology. If one is
interested in the causative effect of just one of these
factors and investigates only one of these risk indicators
without considering the contributory effects of the others,
then the crude measure of the association will probably be
distorted by confounding. In simple terms, a confounding
variable may be thought of as an alternative cause to the
determinant or risk factor under study whose effect is
mixed with that of the study variable. In simple terms an
effect modifier is a third variable, neither the exposure
nor the outcome, which modifies the effect of a specified
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exposure of an outcome. A confounder actually distorts a
comparison and, if not corrected, confounding will produce
a wrong answer whereas an effect modifier (provided it is
not also a confounder) does not distort a comparison, but
provides alternative information about the exposure and
outcome with respect to the third variable.
Historically, the problem of a confounder distorting a
hospital epidemiological study was first observed by McCabe
and Jackson in their investigation of the effects of
bacteraemia with gram negative bacilli (see chapter 2,
section 2.3.1). In this study the species of infection
bacteria was the exposure, mortality was the outcome and
the third extraneous variable having a major influence on
mortality turned out to be severity of the underlying
disease. Following this study it was recognized that
correction for the distorting effect of differing degrees
of health or illness was the major analytic problem facing
hospital epidemiologists.
1.5.1.2 Analysis of multiple variables - statistical
techniques
It is usually impractical to conduct planned experiments
in a hospital population with a concurrent comparison
population that only differs by one variable, because
nature seldom changes only one variable at a time. Methods
have been devised by biostatisticians for analyzing data
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containing information on multiple variables; some of
these statistical techniques are briefly reviewed.
Risk Ratio
The risk ratio is actually the ratio of two probabilities;
the probability of the outcome among the exposed, over the
probability of the outcome in the unexposed (Cornfield
1 951 ) . The risk ratio has an immediate clinical
interpretation. If the risk of the outcome is the same in
both the exposed and the unexposed groups, the risk ratio
will be unity indicating no effect. A risk ratio of 2.0
means the exposed are twice as likely as the unexposed to
have the outcome in question. A risk ratio of 0.5
indicates the exposed are half as likely as the unexposed
to have the outcome. A risk ratio of less than unity
suggests prevention. The terms 'risk ratio' and 'relative
risk' may be used interchangeably.
Stepwise Logistic Regression Analysis
Stepwise logistic regression models allow simultaneous
control of multiple factors. Models are commercially
available (Statistical Analysis Systems Inc. Carey, NC).
Mantel-Haenszel Procedure
Cochran, Mantel and Haenszel have developed methods for
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summarizing discrete data in multiple four-fold tables, or
multiple strata, in direct analogy with generalized methods
of analysis of variance. (Cochran 1954) (Mantel 1959)
(Mantel 1963). These developments allow summary statistics
(chi or chi-square) and summary estimates of risk ratio to
be produced over multiple strata. They are well summarized
in recent textbooks. (Kleinbaum 1982) (Rothman 1986).
The Mantel-Haenszel procedure is the strategyf implemented
in this study to analyze data containing information on
multiple variables.
1.5.2 Nosocomial Infection and mortality
In general, it has been confirmed that nosocomial
infections are associated with mortality, however multiple
factors, for example birth weight and underlying illness,
make substantial contributions to mortality in the same
population and care must be taken in attributing death
directly to nosocomial infection (Goldmann 1981b, 1983).
For example, infants in neonatal intensive care units are
more likely to have nosocomial infections but they are also
more likely to have lower birth weights and specific
underlying conditions. In one study the crude risk of
mortality with nosocomial infection was 2.46 when not
stratified by weight (Hemming 1976) but 1.73 when
stratified by weight (Kleinbaum 1982) (Rothman 1982). Thus
the crude risk ratio of 2.46 is confounded by birth weight
and represents the joint effect of low birth weight and
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nosocomial infection in causing mortality. From this data
it appears that almost half of the crude overall mortality
was the result of low birth weight or its correlates rather
than infection. (Freeman 1987).
In the study of PICU nosocomial infection performed by
Brown (1987) 7 patients died out of a total of 42 infected
patients (17%) compared with an overall mortality rate of
3.4% in the PICU during the study period. This study did
not characterize the population under review by means of
severity of underlying illness and it was unclear whether
mortality in infected patients reflected causality or
merely identified a more severely ill group of individuals.
In 1 988, Craven et al carried out a study in adult ICU
subjects investigating nosocomial infection and fatality.
Thirty risk factors (which included major nosocomial
infections - urine, blood, wound, pneumonia, CNS,
peritonitis/intra-abdominal) were univariately associated
with fatality. After stepwise logistic regression analysis
was performed qv, only nine risk factors remained
significantly associated with fatality and these included
only one site of nosocomial infection namely nosocomial
intra-abdominal infection. Overall, the relative risk of
fatality was increased three fold in patients who acquired
a nosocomial infection (Craven 1988).
There have been some attempts to associate fatality with
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specific bacterial organisms. Miller et al (1987) studied
nosocomial blood stream infections in adult ICU subjects
and suggested that if underlying disease and other
demographic variables (age, sex, race) were accounted for,
infection with either Candida species or Pseudomonas
aeruginosa was an independent predictor of death. In
addition, Pseudomonas aeruginosa, Candida species,
Enterococcus, Enterobacter, Klebsiella pneumoniae and
Serratia marcescens were predictors of the clinical
features associated with shock.
In paediatric patients, there have been no formal studies
associating specific pathogens and fatality though there
are isolated reports of death from both gram positive and
gram negative organisms. Reported outbreaks of nosocomial
viral disease eg., RSV, adenovirus, enterovirus have also
included fatalities. (Krasinski 1985). There is a high
mortality associated with respiratory syncytial virus (RSV)
infection in children with congenital heart disease and
increased pulmonary blood flow (McDonald 1982).
1.5.3 Nosocomial infection and morbidity
With regard to the morbidity of nosocomial infection;
here, conversion of real world events into categorical data
presents formidable difficulties partly because of the
fundamental problem of confounders, and also because there
is a dearth of meaningful, descriptive terminology with
which to express morbidity. Morbidity outcomes for the
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patient and his parents are necessarily sociological and
behavioural rather than purely biological and may only be
applicable in one institution and one patient population.
Terms commonly employed include: 'loss of school days',
'days not up to the bathroom', 'days not up to the
playroom', 'inability to keep up with peers in activities'.
Clearly, none of these is applicable to the measurement of
morbidity in the acute environment of the PICU though,
after discharge, some of these terms may become more
appropriate.
Specific morbidity outcomes using biological diagnoses are
more likely to be robust when applied to other institutions
but in the critically ill child it may be impossible to
distinguish on biological grounds, between the sequelae of
nosocomial infection and the effects of the underlying
disease itself. The clinical illness which follows
nosocomial infection may vary in severity. In some
instances there is little or no alteration in the patient's
condition and infection constitutes mere 'nuisance value'
while in others nosocomial infection may cause a
significant clinical deterioration and may contribute to
death, albeit in a patient who has fatal underlying
disease.
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1.5.4 Nosocomial infection and increased patient care
expenditure
Studies carried out in adult general hospital populations,
have demonstrated a positive association between nosocomial
infection and prolongation of hospital stay / increased
cost of patient care. (Freeman 1979, 1984) (Haley 1980c,
1981) (Scheckler 1980). Estimates are produced by
comparing the length of stay of a group of infected
patients with the length of stay of an uninfected, control
group who are matched by primary diagnosis and operation
(matched cohort study). Freeman in Boston City Hospital
demonstrated that patients with a single nosocomial
infection remained in hospital on average 13 days longer
than matched controls, and those with two such infections
remained on average 35.4 days longer. This study referred
to general ward patients only, and not to ICU patients
(Freeman 1979). In a study of acquired pneumonia in adult
ICU subjects, Craig (1984) demonstrated a threefold
increase in length of stay in infected patients versus a
group of uninfected control patients. The main difficulty
with cohort studies lies in finding adequate numbers of
matching control subjects. An alternative strategy is to
estimate prolongation of stay and increased cost of patient
care by means of subjective impressions of clinicians. In
general, estimates based on epidemiologic comparisons among
patient groups have been substantially greater than those
based on subjective impressions of physicians. Green
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(1982) has used the geometric mean of the ratio of length
of hospitalization of infected patients to matched controls
and suggested that this is more accurate than previously-
used methods involving the arithmetic mean. Estimates of
prolongation of stay are greater in incidence studies than
in prevalence studies.
To date, there have been no estimates of prolongation of
stay due to nosocomial infection in PICU patients though
there have been some crude costing studies of nosocomial
infection outbreaks in general paediatric patients. In the
1 970s an outbreak of nosocomial gastroenteritis was
estimated to cost at least US$ 800 per infection. (Pinner
1982). Infections caused by a number of viruses may
prolong periods of hospitalization (Mufson 1973) (Hall
1975). In 1977, in a study of diarrhoeal illness in
general paediatric patients, medical costs were estimated
to be US$ 836 per infection. (Ryder 1977).
1.6 DESIRABLE FEATURES OF A METHOD OF INFECTION
SURVEILLANCE FOR ROUTINE USE IN THE PICU
I now propose to review the prominent features of an ideal
system of nosocomial infection surveillance, which would be
suitable for routine use in the PICU. The general history
of nosocomial infection surveillance is summarized in
Chapter 2.1 along with strategies of surveillance which are
currently in use.
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The ideal system of surveillance for nosocomial infection
would be efficient and would put the onus of responsibility
on the bedside staff who are in the best position to
determine cause and intervene with assistance from the
Hospital Infection Control service. The SENIC Project
report (section 2.1.3) recommended that strategies of
surveillance for routine use should identify those patients
predicted to be at high risk of developing nosocomial
infection and then target intensive surveillance towards
them. In this way cost is contained and at the same time
surveillance maintains its hospital-wide scope.
In the Hospital for Sick Children, Toronto, members of the
Infection Control Service (E. Ford-Jones, C. Mindorff et
al) have developed a system of infection surveillance
which endeavours to satisfy these requirements. The system
- the Infection Control Sentinel Sheet (ICSS) has been used
satisfactorily throughout the hospital since January 1986.
The sensitivity of the ICSS may be unstable varying with
the type, incidence and severity of nosocomial infection
and with the patient population. It requires evaluation in
the PICU with comparison against a standard of: daily
bedside patient examination, performed by a physician, plus







As discussed in Chapter 1 , formal studies of nosocomial
infection which have been undertaken so far in the PICU,
are somewhat diverse in their purpose and methodology and
methodology is described more precisely in some studies
than in others. Because of these variations, it is
difficult to draw conclusions from the results of
individual studies and comparisons of results between
institutions are hampered. Future studies of nosocomial
infection in the PICU should address those areas of
methodology in which substantial diversity has been
demonstrated namely:
surveillance of nosocomial infection (case finding)
criteria for nosocomial infection
severity of illness scoring
expression of nosocomial infection rates
In the following chapter, I shall discuss each of these
issues.
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2.1 SURVEILLANCE OF NOSOCOMIAL INFECTION (CASE FINDING)
2.1.1. Introduction
It has been observed that individual reports of summary
data do not control for the intensity of surveillance for
nosocomial infection and different institutions employ
different strategies for surveillance. Clearly infection
rates vary in direct proportion to the intensity of effort
to detect infection. Therefore, hospitals (and PICUs) with
more vigorous surveillance methods may look 'worse' than
those with less intensive programmes. (Haley 1985a). The
difficulty and cost of standardising data collection
methods and maintaining their reliability over time may
hamper efforts to measure rates of nosocomial infection and
furthermore, may preclude comparisons between institutions.
Patients in hospitals are particularly prone to infection
and this may threaten the success of their treatment and
even their lives. Over ten years ago, in the United
States, the SENIC study (2.1.3) confirmed that infection
surveillance, control methods and an infection control team
reduced infection rates in hospitals (Haley 1985a).
Nosocomial infection surveillance in its entirety includes
data collection, statistical analysis, dissemination of
results and action. (Hughes 1987). According to Eickhoff
(1969) the following benefits may accrue from an effective
programme of surveillance for nosocomial infection:-
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1. Identification of nosocomial pathogens commonly
encountered.
2. Estimates of the endemic level of nosocomial infection
in the hospital as a whole and in individual high risk
areas or services.
3. Early warning system for epidemics regardless of the
cause or location.
4. Specific investigation through a readily available
mechanism and study group.
5. Continuing emphasis, at all levels of hospital staff,
of the necessity for scrupulous observance of hygiene
principles.
6. Strengthening links between hospital personnel and
Infection Control staff.
7. Comparison of infection rates with other institutions.
8. Satisfaction of requirements for hospital
accreditation.
The last twenty years has seen the emergence of formal
programmes, in most countries, for the prevention of
hospital acquired infection. In 1983 the American Academy
of Pediatrics (AAP) published guidelines for Pediatric
Intensive Care Units (Committee on Hospital Care and
Pediatric Section of the Society of Critical Care Medicine
1983) and emphasised the importance of preventing
nosocomial infections within them. The initiation of
preventive intervention requires the early and complete
detection of infection with, in due course, a reduction in
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its transmission. Detection (or surveillance) may identify
both epidemic and endemic disease.
2.1.2 Historical
The history of nosocomial infection surveillance in North
America spans a thirty year period (Hughes 1987). In the
United Kingdom there is some experience in paediatric
patients from fifty years ago. (McKhann 1938) (Harries
1935); the pivotal role of the 'infection control sister'
was reported in the early 1960s. (Gardner 1962) (Davis
1963) (Bradberr 1966).
The classic prevalence surveys of nosocmial infections, at
all sites, were conducted at the Boston City Hospital in
1964 by Kislak and in 1967 by Barrett. At about the same
time six hospitals of 1 76 - 507 beds undertook pilot
surveillance projects with the Center for Disease Control
(CDC). In 1974 the SENIC Project (see below) was initiated
and its results were published in 1985. In 1976 the Joint
Commission on the Accreditation of Hospitals (JCAH)
specifically addressed infection control standards and
established requirements for accreditation in US hospitals.
Surveillance for nosocomial infection became a requirement




In January 1974 the Center for Disease Control (CDC)
initiated the SENIC Project (Study on the Efficacy of
Nosocomial Infection Control) to determine whether
infection surveillance and control programmes established
in a random sample of US hospitals had a significant
influence on the subsequent change in the hospitals'
nosocomial infection rates over a five year period. (Haley
1980a). The project was designed to study the efficacy
question separately for infections involving four different
sites namely urinary tract, surgical wounds, blood streams
and lower respiratory tract (both post operative pneumonias
and pneumonias in medical patients).
The final report of the SENIC study made several noteworthy
observations. (Haley 1985). Importantly the nosocomial
infection rate increased by an average of 3% annually in
those hospitals that did not establish infection
surveillance and control programmes between 1970 and 1976.
The critical components of an optimally effective
nosocomial infection surveillance and control programme
were shown to include a balance between surveillance and
control efforts, the presence of one infection control
practitioner for every 250 hospital beds, a trained
hospital epidemiologist and the reporting of surgical wound
infection rates to surgeons. At the four sites studied,
surveillance was most important in the prevention of post
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operative pneumonias and nosocomial urinary tract
infections.
The SENIC study was not able to determine precisely which
methods and schedules should be used in performing
surveillance for nosocomial infection. At the time of data
collection most centres were detecting infections in most
areas of the hospital on a continuous daily basis using
ward rounds, review of laboratory reports and similar
clinical activities. Only a few centres were relying on
periodic prevalence studies (limiting surveillance to
specific wards or units) or other 'targeted' surveillance
methods. It was suggested that 'targeted' surveillance -
limiting surveillance to groups of patients predicted to
be at high risk of nosocomial infection, would reduce the
expense of surveillance while maintaining its continuous
hospital wide scope. It was concluded however, that
further studies were needed to confirm that 'targeted
surveillance' was as effective as the 'traditional
approach' evaluated in the SENIC project.
In Chaper 1 section 6, I reviewed the prominent features of
a system of nosocomial infection surveillance which would
comply with the recommendations of the SENIC Project
report. It is suggested that a novel system of
surveillance, currently in routine use in the Hospital for
Sick Children, Toronto approaches this ideal. The system -
the Infection Control Sentinel Sheet (ICSS) is applicable
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hospital-wide; it 'flags' patients at risk of nosocomial
infection and targets more intensive surveillance towards
them. One of the aims of this study will be to evaluate
this method of 'targeted surveillance' in the PICU
comparing it with the 'traditonal' approach of daily
bedside examination and chart review.
2.1.4 Infection Control in the United Kingdom
In the United Kingdom the need for an organization to
investigate and control infection in hospitals has been
recognized for many years and recommendations have been
made in a number of official publications (Medical Research
Council 1941, 1944) (Ministry of Health 1951, 1959)
(Central Health Services Council 1959). These were
concerned principally with the establishment of control of
infection officers (CIOs) and control of infection
committees (CICs). In 1962 the appointment of an infection
control sister was recommended (Gardner 1962), and
subsequently the concept of an infection control team
became well established. (Lowbury 1975). Recent, poorly
controlled outbreaks of infection - such as the food
poisoning caused by Salmonella at Wakefield Hospital - have
focused attention on the strategies currently used for
curtailing hospital infection and it is suggested that pre¬
existing arrangements, despite their success in most
British hospitals, may require enhancement. (DHSS 1986).
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In 1988 the Joint Department of Health and Social Security
and the Public Health Laboratory Service commissioned the
Cooke report - Hospital Infection Control - Guidance on the
Control of Infection in Hospitals. The British government
now wants health authorities to draw on this report and
ensure that they have clear management arrangements for
controlling hospital infection. The Cooke report
identifies the district general manager (advised by the
district's hospital infection control committee) as the
individual responsible for the arrangements for infection
control and recognizes the crucial role played by the
infection control doctor. A report of a survey of the
Hospital Infection Society in 1986 showed that 98% of all
health authorities in England and Wales have control of
infection officers, four fifths of whom are consultant
medical microbiologists. (Howard 1988). Clinical demand,
however, may make it impossible for a single handed
microbiologist to provide a 24 hour service, and there may
be justification for implementing the recommendation of the
Royal College of Pathologists for two microbiologists in
large hospitals. Similarly a single infection control
nurse may no longer be adequate for districts with greater
than 750 beds. (The requirement in the United States is
for one nurse for every 250 beds).
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2.1.5 Surveillance Strategies
As a rule, one method of surveillance is used in all
clinical areas throughout an institution and surveillance
is either prospective or retrospective. Prospective study
involves monitoring the patient while he is still
hospitalized; retrospective study involves post discharge
review of medical records by a variety of personnel. The
SENIC study showed the sensitivities of prospective and
retrospective techniques to be similar (0.76 and 0.74
respectively) (Haley 1980b); other studies have also
reported favourably on retrospective review. (Wenzel 1976)
(Gross 1980). In contrast Birnbaum (1981) and Blake (1980)
found retrospective review less acceptable. It would
appear that retrospective review can be highly effective in
identifying nosocomial infection, but rigorous training and
quality control are required.
A number of acceptable strategies for the surveillance of
nosocomial infection have been described and these are now
reviewed in association with an appraisal of their merits
and limitations. Systems of surveillance are either










2) Process assessment - review procedures and
practices.
LABORATORY BASED
1) Identifying nosocomial infections
Surveillance for infections of all types
Bacteraemia surveillance
Critical organism surveillance
2) Identifying outbreaks - threshold analysis
3) Surveillance of the environment
2.1.5.1. PATIENT BASED STRATEGIES
1) Outcome Assessment
CDC Method
The Centre for Disease Control (CDC) patient based
surveillance system remains the standard against which all
other systems are judged. (CDC 1972) (Haley 1986). The
daily activities consist of reviewing microbiology
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department records for positive cultures plus ward rounds,
daily if possible, to review the records of patients who
are isolated, febrile or receiving special
treatments/antibiotics. In addition, visits with nurses
and physicians, as well as random chart review, are
helpful. Other sources of information include personnel
health, and post-discharge surveillance of neonates and
patients who have undergone surgery. Autopsy reports are
also considered a source of information though one recent
study suggests that their value is limited (Crossley 1983).
The CDC system has the following advantages
a) It provides a current, hospital wide, comprehensive
review of nosocomial infections.
b) It provides data that are comparable to those reported
by other institutions. (Lynch 1985).
c) The causative organisms and their antibiotic
susceptibilities are defined.
d) The Infection Control Practitioner (ICP) has a high
profile.
The major disadvantage of the system is that it is very
labour intensive - 50% of ICP time.
Limited Periodic Surveillance
In 1973 Chelgren and LaForce described their adaptation of
the CDC method. Full surveillance of the CDC type is
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performed for one month quarterly with interim surveillance
for bacteraemia only.
This system has the following advantages
a) Time spent for surveillance is reduced (50% of ICP
time during period of CDC surveillance, reduced to 5%
of ICP time during interim surveillance).
b) Data can be compared with national data and reports
from other institutions using similar techniques.
The major disadvantage of this method is the potential for
missing problems during the period of interim surveillance.
Kardex Review
This system, described in 1976 (Wenzel 1976a), uses the
Nursing Kardex(R) which is a form summarizing the nursing
care plan for each patient. The Infection Control
Practitioner (ICP) reviews the Kardex for each patient
searching for predefined clues suggestive of infection e.g.
soaks, antibiotics; surgery; indwelling devices. The
medical records are then reviewed for evidence of
nosocomial infection. The system is less time consuming
than the CDC method (16 hours compared to 60 hours of ICP
time per week); it may detect up to 82% of infections, but
it is dependent on centralised nursing care plans which all
hospitals do not have. Wenzel and colleagues evaluated the
system in critical care areas and found that it detected
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48% of nosocomial pneumonias and 45% of bacteraemias.
(Wenzel 1981) (Landry 1982).
Periodic Prevalence Survey
In this method point prevalence surveys are performed
(Latham 1981) and from such data incidence figures are
inferred. (Rhame 1981) (Freeman 1981b). The relationship
between incidence and prevalence of infection is discussed
in 2.4.3.
2) Process Assessment
Rather than measure the outcome of nosocomial infection,
compliance with patient care and infection control
practices may be measured. (Friedman 1984). Measurement
of compliance alone, without assessing outcome, is adequate
when the practice being examined is known to be effective
in preventing nosocomial infections. When the
effectiveness of the practice is unknown, measurement of
compliance is unsatisfactory.
2.1.5.2. LABORATORY BASED STRATEGIES
Some recent work (Gross 1980) has indicated that laboratory
surveillance may be efficient but there are potential
problems namely:-
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a) failure to detect infections for which no useful
culture is obtained e.g. deep surgical wound
infection, ventilator associated pneumonia, otitis
media.
b) failure of the laboratory to provide certain
diagnostic tests e.g. viral culture.
c) failure to standardise the application of diagnostic
tests.
1) Identifying nosocomial infections
Surveillance for bacteraemia
This is an important element of a surveillance programme
because the positive predictive value of a blood culture
for infection is high. (Rose 1977) (Holzman 1977). The
problem with site specific surveillance is that it will
fail to identify the majority of infected patients who are
infected at other sites.
Organism specific surveillance
In this system a list of organisms, which are of
epidemiological importance to an institution, is compiled
e.g. methicillin resistant Staph Aureus, Clostridium
difficile, aminoglycoside resistant gram negative bacilli.
Complete case review is undertaken whenever a laboratory
test, culture or otherwise, indicates infection is likely.
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(Laxson 1984). The system has limitations similar to those
of site specific surveillance i.e. it will fail to identify
patients infected with 'unlisted' organisms.
2) Identifying Outbreaks
Systematic approaches for using laboratory information for
detection of outbreaks have been described. (Warner 1961)
(McGuckin 1979) (Parkhurst 1985) (Birnbaum 1984) (Schifman
1985). Usually a threshold is developed to signal
significant deviations and when this is exceeded an
investigation is automatically triggered.
3) Surveillance of the Environment
The role of environmental surveillance in infecton control
programmes was once a major issue, but is less so today.
The appropriate nature, scope and use of this activity are
further discussed by McGowan (1981) and in the Centers for
Disease Control - Guidelines for Hospital Environmental
Control (1981).
Different strategies of infection surveillance have
different advantages e.g. speed of lab based system,
completeness of bed side exam, and also different secondary
gain e.g. nurse reporting may increase interest in
infection control. The relative merits of the systems have
not been systematically quantified and currently hospitals
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are encouraged to be flexible and responsive to specific
needs rather than adopt a static approach. (Abrutyn 1987).
2.1.5.3 Sensitivities of different strategies of
Surveillance
The sensitivities of a number of surveillance methodologies
relative to bedside examination and chart review are tested
in Table 2.
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(Adapted from Freeman 1981(a) and Thompson 1987).
** by definition, all other sensitivities are referable to
this standard.
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2.1.5.4 Published PICU Studies - Surveillance Strategies
Used
In the published PICU surveys; several combinations of the
available surveillance systems have been used. The study
by Welliver (1984) was performed hospital-wide;
surveillance consisted of:-
1) CDC system - infection control nurse (ICN) review of
microbiology reports and inpatient charts.
2) Kardex review - also done by ICN.
3) review of patient record at time of hospital discharge
- trained medical records department clerk.
In the study by Donowitz (1986b) surveillance methodology
was described as 'Prospective surveillance, routinely
performed by trained infection control practitioners'.
More precise details of surveillance methodology were
unavailable.
Brown et al (1987) obtained infection data from patient
chart review, radiology reports and results of microbiology
studies. Infection control personnel daily surveyed the
critical care area.
The study by Milliken et al (1988) which was performed in
this institution, (Hospital for Sick Children, Toronto)
used the CDC method i.e. review of microbiology reports and
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inpatient charts by infection control nurses. To date, no
study has performed a 'gold standard' of surveillance
comprising daily bedside examination of patients plus daily
review of in-patient charts.
2.1.6 Application of Diagnostic Tests
Observed infection rates depend in part on the propensity
of physicians to order diagnostic tests (Haley 1985b). The
failure to apply diagnostic tests will understate the
incidence of those infections for which a culture or other
diagnostic intervention is required. These include blood,
lung and urinary tract infections and, of particular
interest in paediatric patients, viral infection of the
respiratory or gastrointestinal tracts.
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2.2 CRITERIA FOR NOSOCOMIAL INFECTION
The second area of methodology which merits discussion, is
the criteria used for nosocomial infection. Broadly
speaking, any definition of nosocomial infection is
somewhat artificial. In most studies infections are
considered to be nosocomially acquired if the first
sampling from which micro-organisms are obtained is on or
after the third hospital day. Likewise, PICU nosocomial
infection would be that developing after 72 hours in the
PICU. Clearly such a definition does not guarantee that
offending pathogens are, in the strictest sense, of
hospital (or PICU) origin.
Infection criteria are not necessarily rigorous definitions
of disease but rather operational terms agreed upon by key
hospital staff for hospital use, which may or may not
include microbiologic aetiology. The Centers for Disease
Control (CDC) has provided criteria for definition of
infection, but it is recognized that some of these are
outmoded and some are too brief to cover many clinical
situations. (US DHEW Publ. 87-8314, 1975).
Clearly certain definitions are inadequate - for example
'pus at site' for wound infections, a term which excludes
deep post operative wound infections. Nosocomial pneumonia
is difficult to define (and, therefore, to diagnose),
particularly in ventilated patients. A number of
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definitions exist and none is entirely satisfactory. Any
definition which includes 'sputum production' is inadequate
since it excludes pneumonia in young children where sputum
production is usually absent. In intubated patients it may
be difficult clinically to distinguish between bacterial
colonisation of the tracheobronchial tree and nosocomial
pneumonia; pulmonary infiltrates often occur on a non¬
infectious basis.
Salata et al studied endotracheal aspirates from intubated
adult ICU patients and suggested that serial examination of
aspirates for elastin fibres in association with graded
Gram stains could provide a means of early diagnosis of
nosocomial pneumonia in these subjects (Salata 1987). On
the other hand Golden et al studied the use of Gram stained
smears and semi-quantitative cultures of endotracheal
aspirates to diagnose pneumonia in intubated patients in a
paediatric intensive care unit and demonstrated a poor
correlation firstly between endotracheal aspirates and
radiographic findings and secondly between the
microbiological findings in aspirates and the results of
blood cultures and postmortem examinations. They concluded
that endotracheal aspirates were of questionable value in
diagnosing the presence of pneumonia or its aetiology in
intubated patients in the PICU (Golden 1987).
The diagnosis of bacterial pneumonia in PICU patients is
primarily based on clinical and radiographic findings and
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definitions of infection should reflect this fact. The
most useful definition is probably "infiltrate on chest
Xray, not present on admission, and not attributable to a
non-infectious cause, with or without microbiological
confirmation".
With regard to bacteraemia; the CDC definition considers
bacteraemia secondary to a focal infection as 'secondary
bacteraemia' while the primary focus is tallied with other,
similar primary infections. This contrasts with the SENIC
Project definition which considered bacteraemia secondary
to a focal primary infection and bacteraemia without a
recognized primary infection in the same category.
Definitions of viral infections may be "clinical" or may
require recovery of the agent (Welliver 1984). In
focussed studies such as those reporting infection
following cardiovascular surgery more precise terms have
been used (Edwards 1983).
2.2.1 Published PICU Studies - Criteria for Nosocomial
Infection
Criteria for nosocomial infection have been more precise in
some studies than in others. Donowitz (1986b) defined
nosocomial infections in the text of the methodology
however only four sites of infection were detailed - blood
stream, pneumonia, urinary tract and post operative wound
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Milliken (1988) supplied definitions of nosocomial
infection as an appendix to his paper. Nine sites of
infection were discussed and blood stream infections were
sub-divided into primary and secondary types. Other
studies have made reference to the CDC criteria with or
without modifications (Brown 1987) (Welliver 1984).
2.3 SEVERITY OF ILLNESS SCORING IN PICU PATIENTS
The third area of methodology which merits discussion is
severity of illness scoring. To date, published studies
performed in the PICU, have analyzed nosocomial infections
in terms of site, clinical specialty and use of therapeutic
procedures or devices. The severity of the underlying
illness has not been measured in paediatric patients
although it is recognized as the single most important
factor determining the risk of acquiring infection and its
outcome.
2.3.1 Historical
McCabe and Jackson first attempted to define a patient
population, using severity of illness, in 1962. These
workers studied adult patients with disease which they
designated as 'non-fatal', 'rapidly fatal' or 'ultimately
fatal', and identified that the nature and severity of the
underlying disease was the most important factor
determining the outcome of bacteraemia. In this
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prospective study, the admitting house officer assigned
every new admission to one of three groups based on the
severity of the patients's illness at that time. This
information was recorded on a work sheet on the front of
the patient's medical record. The infection rates in
patients with rapidly fatal, ultimately fatal and non fatal
disease were 27.2%, 13.1% and 2.8% respectively. The
reliability and validity of this classification have not
been determined and furthermore their terms are not
applicable in an institution dealing with emergent
survivors e.g. neonatal graduates.
Conventional methods for classifying patients with respect
to utilisation of health care resources are based almost
exclusively on diagnostic criteria and staging (Horn 1983)
(Gonella 1984). The greatest problem with staging
methodology is the fact that it examines each disease
separately but does not link disease to look at the total
impact on the patient. Hence only the principal identified
condition is used in the measure of severity of illness and
other secondary conditions, unrelated to the principal
illness, are not captured. Two systems available for
general application are Diagnosis Related Groups (DRGSs)
and the Johns Hopkins severity of illness score; both have
evolved primarily for costing purposes.
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2.3.2 Diagnosis Related Groups (DRG)
The Diagnosis Related Group based system of classification
was developed at Yale University (Fetter 1981) (Grimaldi
1981) ; it assumes that each DRG contains a clinically
related group of patients with similar utilization of
resources. There are 470 DRGs of which 51 (10.8%0 relate
exclusively to paediatric disease entities. The
disadvantages of this system are firstly that teaching
hospitals have a higher proportion of complex patients who
are not identified and secondly, it does not capture
important differences in the severity of disease within a
diagnostic group (Horn 1983, 1985a, 1986) (Flint 1986)
(Lagoe 1986) (McMahon 1986) (Pasternak 1986) (Phibbs 1986).
2.3.3 Johns Hopkins Severity of Illness Score
This system was developed in response to the weaknesses of
DRGs (Horn 1985b). It assigns to each patient, at or after
discharge, a severity of illness score on a four level
scale determined from the score for each of the 7 different
dimensions as follows:-
1) stage of principal diagnosis at admission - greatest
extent of organ involvement.
2) complication of diagnosis as a result of therapy or
hospitalization.
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3) interactions - pre-existing problems other than the
principal diagnosis and its complications.
4) dependency - level of care required.
5) non-operating room procedure - procedures are assigned
to one of four levels with 3 and 4 required for life
support; the highest level of procedure, rather than
the total number of procedures, determines the score.
6) rate of response to therapy - principal diagnosis,
complications and interactions. This refers to acute
illness only and does not reflect change in underlying
disease for which no progress is expected.
7) residual symptoms at discharge.
To determine the score a rater scores each of the 7
dimensions at one of 4 levels; by examining the pattern of
scores, an overall 4 point scale score is assigned. The 4
levels of severity are an ordinal scale from least severe
(level 1) to most severe (level 4). A comparison of four
different types of hospital with respect to total costs and
lengths of stay shows that the academic teaching hospital
does not have significantly higher charges than other
hospitals when severity of illness and major operating room
procedures are controlled for. The principal limitation of
this method is that, so far, the computer branch system has
been validated only for adult patients and not for
paediatric patients.
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2.3.4 Clinical Classification Scoring
Clinical classification scoring is a qualitative assessment
of care requirements (Civetta 1973) (Cullen 1976). Class
I patients need only routine hospital care and are not
normally admitted to the ICU. Class II patients are
physiologically stable and are admitted to the ICU only for
monitoring or observation; Class III patients are
physiologicaly stable but need ICU nursing care; Class IV
patients are physiologically unstable, and need frequent
assessments and interventions by ICU physicians and nurses.
This system can be applied to the PICU patient but
obviously other factors, apart from severity of illness,
influence the selection of patients for PICU admission.
These other factors include hospital policy, and the
available facilties for post-anaesthesia recovery and high
dependency nursing.
2.3.5 Therapeutic Intervention Scoring System (TISS)
Therapeutic and monitoring modalities can be assessed using
the Therapeutic Intervention Scoring System (TISS score)
which quantifies the amount of therapy instituted in each
patient and can be used to define underlying illness
severity (Cullen 1974). The system consists of 76
therapeutic and monitoring interventions; one to four
points are assigned based on invasiveness and complexity of
the intervention. This system has been applied to PICU
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patients (Rothstein 1982). For paediatric use 'frequent
infusion of blood products' (normally 5 units of blood) is
modified to 'use of 20ml/kg of blood'. Otherwise the
system is similar to that used in the adult ICU. Balloon
counterpulsation and extracorporeal membrane oxygenation
(ECMO) are not routinely available in the PICU.
The limitation of the TISS score is that it reflects the
severity of illness in a heterogeneous population only if
one assumes that the pathophysiology of organ dysfunction
follows common paths requiring standard interventions;
that all physicians intervene similarly and appropriately
at each level of critical illness; and that all levels of
intervention can be supplied if necessary.
By assessing therapeutic needs the CCS and TISS systems
only indirectly reflect severity of illness and more direct
methods of assessment, based on physiological principles,
are preferable.
2.3.6 Acute Physiology and Chronic Health Evaluation
(APACHE Score)
In 1981 Knaus et al developed the first physiology based
classification system to quantify severity of illness in
adult ICU patients - the Acute Physiology and Chronic
Health Evaluation (APACHE) score (Knaus 1981). The
prototype employed 34 variables though this number was
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later reduced to 12 when APACHE II was developed (Knaus
1985). The variables reflect mostly the cardiovascular,
respiratory, neurologic and metabolic systems; the value
recorded is based on the most deranged reading during the
first 24 hours that the patient is in the ICU. The degree
of deviation from normal is defined as either high abnormal
range or low abnormal range with a maximum of 4 points
assigned to each variable. The sum of the scores for each
variable provides the Acute Physiology Score (APS). Age
and severe chronic health problems reflect diminished
physiological reserve and have been incorporated into the
system.
While the APACHE system was not primarily developed to be
used for individual patient treatment decisions, APACHE II
can provide the clinician with a systematic evaluation and
an improved understanding of how an individual patient's
severity of illness influences outcome (Knaus 1982, 1983).
The principal limitation of this system is that variable
ranges are not age adjusted hence, it is not applicable to
infants or children.
2.3.7 Physiological Stability Index (PSI)
In 1 984 Pollack et al developed and published a severity of
illness scoring system for use in the Paediatric Intensive
Care Unit - the Physiologic Stability Index (PSI) (Yeh
1984). The PSI characterises the patient's severity of
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illness by quantifying the degree of derangement in 7 major
physiologic systems independent of diagnosis. The ranges
of some of the measured variables are appropriately
adjusted for different ages. The system evolved from
meetings of paediatric intensivists; most of the PSI
impacts on the respiratory, cardiovascular, neurologic and
metabolic systems. A total of 34 routinely or frequently
measured variables from these seven systems was chosen.
After assessing the degree of abnormality, each variable
was assigned a score of 1 , 3 or 5 which reflected the
clinical importance of the derangement, but not necessarily
the amount of deviation from the normal value. A score of
1 was assigned for a variable range that was not sufficient
to mandate a change in therapy. A score of 3 indicated
sufficient concern that it would lead most physicians to
change therapy. A score of 5 indicated an immediate life
threatening situation. Individual scores are added to
obtain the final PSI score. The system has been validated
for ages above and below 12 months. Unlike APACHE, the PSI
does not have a chronic health assessment. (In fact Knaus
found this feature to be superfluous when using APACHE to
predict outcome in adult patients). The admission day PSI
is least affected by therapeutic interventions and probably
reflects severity of illness the best. The PSI severity of
illness scoring system is detailed in Figure 1.
91
Figure 1 Physiologic Stability Index (PSI)
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Figure 1 Physiologic Stability Index (PSI)
1+ 3+ 5+
All ages
Hemoglobin (g/dl) 18.0-22.0 3.0-5.0 <3.0
5.0-7.0 22.1-25.0 >25.0
WBC (cell/mm3) 3-5,000 <3,000
20-40,000 >40,000
platelets (cell/mm3) 20-50,000 <20,000
PT/PTT >1.5 x control
FSP (ug/ml) >40
All Ages
BUN (mg/dl) 40-100 >100








Albumin (g/dl) 1.2-2.0 <1.2
All ages
Sodium (meq/1) 115-125,150-160 <115, >160
Potassium
(meq/1) 3.0-3.5 2.5-2.9 <2.5
Calcium (mg/dl) 7.0-8.0 5.0-6.9 <5.0
12.0-15.0 >15.0








It was postulated by Pollack and his co-workers that the
different mortality rates observed within different PICUs
were due to differences in patients' underlying severity of
illness. This hypothesis was tested and confirmed in a
multi-institutional study which used the PSI system to
assess severity of illness, and which involved 9 PICUs
across the United States. Results indicated that a six
fold difference in mortality rates, observed initially
between different institutions, disappeared when rates were
adjusted for differences in severity of illness. (Pollack
1987). It was thereby confirmed that the most important
predictor of mortality in the PICU was the severity of the
underlying disease. Admission PSI scores of <10 generally
correspond to low mortality risks (<5%); scores of 16-25
correspond with an observed mortality of between 30% and
40%; scores of >25 correspond with an observed mortality of
>70%.
2.3.8 Paediatric Risk of Mortality (PRISM).
A simplified version of the PSI, the PRISM rPaediatric Risk
of Mortality) score has subsequently been developed
(Pollack 1988). The number of variables has been reduced
to 23, and the measurement of all physiologic values is
mandatory. This eliminates concerns about the assumption
that if a variable is unmeasured then it is normal. Using
the existing data base of 2642 patients from 9 PICUs, an
estimation group and a validation group were formed.
94
Statistical techniques including univariate analysis and
multivariate analysis were used to construct the PRISM
score. The performance of PRISM was tested using goodness-
of-fit tests and receiver operating characteristics (ROC)
analysis. The PRISM score was demonstrated to perform
equivalently to the organ weighted PSI system. The PRISM
score for children is detailed in Figure 2 and that for
infants is detailed in Figure 3.
95
Figure 2 PRISM Score Child
Variable Value Score





Diastolic B.P. >110 6
(mmHg)
Heart rate >1 50 4
(beats/min) <80 4







Glasgow Coma Scorec <8 6
Pupils unequal or dilated 4
f ixed and dilated 1 0





Calcium 1 .75-2.00 2









a Cannot be assessed in patients with intracardiac
shunts or chronic respiratory insufficiency; requires
arterial blood sampling.
b May be assessed with capillary blood gases.
c Assessed only if there is known or suspected CNS
dysfunction; cannot be assessed in patients during
iatrogenic sedation, paralysis, anaesthesia etc.
Scores <8 correspond to coma or deep stupor.
d Use measured values.
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Figure 3 PRISM Score Infant
Variable Value Score





Diastolic B.P. >11 0 6
(mmHg)
Heart Rate >160 4
(beats/min) <90 4







Glasgow Coma Score0 <8 6
Pupils unequal or dilated 4
f ixed and dilated 1 0
pt/ptt 1 .5 x control 2
















Cannot be assessed in patients with intracardiac
shunts or chronic respiratory insufficiency; requires
arterial blood sampling.
May be assessed with capillary blood gases.
Assessed only if there is known or suspected CNS
dysfunction, cannot be assessed in patients during
iatrogenic sedation, paralysis, anaesthesia etc.
Scores <8 correspond to coma or deep stupor.
Use measured values.
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2.3.9 Severity of Illness - Concepts and Measurements
Having reviewed the strategies available for quantifying
severity of illness, I would like to briefly consider some
of the associated fundamental concepts. This discussion is
based on an article by Stein et al published recently in
the Lancet (Stein 1987).
Severity of illness is not an absolute concept and,
depending on whether severity is a predictor, a control or
an outcome variable, different measures will be of
interest. Even when a biological manifestation of a
condition can be identified, severity cannot be quantified
because the clinical manifestations are the product of
interactions between biological determinants, genetic
composition and environment. Hence, to grade severity,
categories are employed similar to those used for
assessment of socioeconomic status or intelligence. In
essence, three categories of illness severity are
recognized and commonly measured - physiological (or
morphological) severity, functional severity and burden of
illness.
2.3.9.1 Physiological Severity
Physiological status is assessed quantitatively from
laboratory tests or anatomical reports. These measures
reflect interactions of biological severity with
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environmental factors including medical treatment. Overall
physiological severity indicators are of little use in
patients with rare conditions or multiple health disorders,
or across a spectrum of different conditions. Many
conditions lack markers and, where primary conditions are
accompanied by other disorders, the combined effects are
not necessarily additive. Furthermore, although a given
marker may change as a result of several conditions, most
markers do not apply across disease categories. Exceptions
to this rule of condition specificity are the APACHE system
(Knaus 1985) and the PSI/PRISM systems (Yeh 1984) (Pollack
1984, 1987c) though, in fact, some workers consider these
systems to provide a measure of functional status rather
than physiological severity.
2.3.9.2. Functional Severity
Functional severity is the impact of the disorder on an
individual's ability to perform age-appropriate activities,
irrespective of illness type, and under a broad range of
circumstances. Functional severity reflects the effect of
a condition on a final common pathway; namely the ability
to conduct daily life. It is often assessed by items such
as days missed from school or work, intellectual
dysfunction due to disease, or the inability to play games
or climb stairs.
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2.3.9.3. Burden of Illness
Severity may also vary in terms of the impact of the
disease or condition on the family or on society and this
concept is the burden of illness. Any condition may be
viewed as severe if it places a large burden on society in
financial, emotional or social terms. Burden of illness
measures, like functional severity measures, are applicable
across diseases. The economic burden of illness underlies
the DRG reimbursement system (see Section 2.3.2) and the
Johns Hopkins scoring system (see Section 2.3.3).
2.3.9.4 Implications
A framework for defining illness severity may aid in
clarifying assumptions underlying clinical and health care
research. Three interacting categories may be
distinguished. Most measures of physiological or
morphological severity are disease specific and are
affected by medical management and patient compliance.
Functional severity indicates the effect of the disease on
the person's ability to do things healthy peers do and is
applicable where multiple conditions co-exist or across
different diseases. Burden of illness includes the impact
on the family and on society, and also applies across
diseases.
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2.4 EXPRESSION OF NOSOCOMIAL INFECTION RATES
2.4.1 Incidence of Infection
The occurrence of nosocomial infections is most often
computed by dividing the number of infections acquired
during a given month by the number of patients discharged
(or admitted) during that month (Freeman 1981a). This
parameter is called the infection rate, the incidence rate,
or, less properly, the incidence. This derivation has the
following associated problems
1) the duration of stay is ignored
2) the denominator excludes patients if they were not
admitted and discharged within the same month
3) the 'rate' is really an incidence ratio
4) the 'rate' precludes inter/intra hospital comparisons
5) the 'rate' fails to recognize simultaneous infections
in one individual
Although more complicated to calculate, a definition of the
nosocomial infection rate as infections per 1,000 patient
care days will correct for long hospital stays and avoid
falsely high estimates of infection rates. This will allow
comparisons of infection rates over time and across
locations by separating the effect of long hospital stay
from the effect of high daily risk.
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In the SENIC Project the following measures were
calculated. (Haley 1985a):-
The Infection Percentage - the percentage of admissions in
which one or more infections occurred.
The Infection Ratio - the ratio (times 100) of the total
number of nosocomial infections to total admissions.
The Incidence Density - the ratio (times 1,000) of the
total number of nosocomial infections to the total number
of days of hospitalization spent by all patients admitted
to the hospital during a 12 month period.
The assumption is made that the number of admissions equals
the number of discharges and the duration of stay is
constant.
2.4.2 Prevalence of Infection
The prevalence rate is determined at a single point in time
(Freeman 1980). The number of both active and cured
nosocomial infections that are or have been present in
patients hospitalized on a given day is divided by the
number of patients present at the time of the survey. Both
active and cured infections are included because of the
difficulty in deciding the point at which an infection
becomes cured. In practice, the 'single point in time' is
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usually taken to be the interval (generally several hours)
during which the survey team visits the ward. Since very
few patients acquire a nosocomial infection during the
first few hours of hospitalization, this comes very close
to a true point of prevalence.
2.4.3 Relationship between Incidence and Prevalence
The following mathematical equation associates incidence
(I) and prevalence (P).
I = P x
L A
L N - I N T
I = incidence rate of nosocomial infection
P = prevalence rate of nosocomial infection
LA = mean length of hospital stay for all patients
LN = mean length of hospital stay for patients who have
one or more nosocomial infections
INT = mean interval from admission to the first
nosocomial infection in those patients who have had







It is recognized that an epidemiological study of this kind
involves the accumulation and storage of large amounts of
patient related data which, in turn, raises questions of an
ethical nature particularly with regard to medical
confidentiality.
Principles of bioethics have evolved from about the 1 6th
century BC (Ad hoc Committee on Medical Ethics 1984). In
this century; in 1948 the World Medical Organization
adopted the Declaration of Geneva; the Nuremberg Code and
the Declaration of Helsinki followed. The latter two deal
more specifically with human experimentation.
Broadly speaking, ethical issues have been perceived in
epidemiology for more than ten years and were first
addressed by Susser et al in 1977 who dealt with problems
regarding the choice of research questions, research design
and the use of human subjects in research. In 1978, their
dissertation entitled "Ethics in Epidemiology" was
published in the Annals of the American Academy of
Political and Social Science (Susser 1978).
At about the same time Gordis addressed questions of access
to data, data privacy and the limitations imposed on
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epidemiologic research through inaccessability to data
sources. (Gordis 1977). For additional discussion
regarding ethics in epidemiology the reader is referred to
the excellent review article, published recently by
Soskolne, entitled 'Epidemiology: questions of science,
ethics, morality and law' (Soskolne 1989).
The concept of medical confidentiality is almost as old as
medicine itself. The Hippocratic Oath, (or its modern
counterpart the Declaration of Sydney), represents the
roots which sustain the intra-professional code of conduct,
and that is, in practice, the patient's main safeguard of
what is generally considered to be his right. (Walters
1974, 1982). In Principles of Biomedical Ethics, Beauchamp
and Childress argue that patient confidentiality and
privacy are based on the fundamental principle of autonomy
or respect for persons, though exceptions to
confidentiality are sometimes necessary from a practical
standpoint and are also morally defensible (Beauchamps
1 983) .
Problems have emerged over the past three decades
concerning the use of confidential medical information in
research, particularly when the investigator is not
involved in the care or treatment of the individual
concerned (Gordis 1980).
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3.2 USE OF COMPUTER PROGRAMMES IN CLINICAL MEDICINE
With regard to medical confidentiality; clearly there is
no necessary difference in content between conventional
written records, and data in computer systems. The
efficiency of automated systems may make violation of
medical confidentiality easier, and, because of the amount
of data on file, the damage to the patient may be
proportionally greater. Computer systems and computers,
therefore, involve a special degree of responsibility for
those who control them (Miller 1985).
Over the last twenty years various countries have
legislated on the question of access to, and protecton of,
personal data held in computer banks. The State of Hessen,
Federal Republic of Germany, was the first to do so in 1970
(International Commission of Jurists).
The British Government legislated in 1984 when Parliament
passed the Data Protection Act. The protection of persons,
about whom computerized information is stored, lies
essentially in preventing the holding of inaccurate
information or of concealing the fact that information is
stored at all. Under the Act the subject of the data has
the right to see that which pertains to him and to ensure
its accuracy.
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The Government of the United States of America enacted data
protection legislation in the Privacy Act 1974 and in 1981
refinements were made concerning the data systems of the
National Center for Health Statistics. In fact, by 1984,
the privacy laws in the United States had been found to be
an impediment to the conduct of epidemiological research,
and a formal report was made on this problem by the US
Environmental Protection Agency in 1984 (Task Force on
Environmental Cancer and Heart and Lung Disease, 1984).
Recently Blake has reviewed issues of confidentiality
associated with the use of computerized medical records.
(Blake 1982). She implies that developments in the legal
arena require hospitals and others in charge of such
records to take special precautions against unauthorized
disclosure of identifiable medical information. In Blake's
opinion, specific guidelines should be used to avoid legal
liability for breach of patient confidentiality however,
restrictions should be carefully formulated and there must
be a compromise between assuring patient confidentiality
and providing necessary patient information to treating
physicians.
The technology for protecting information stored on
computers is not perfect (Gillard 1983) (Brannigan 1984)
(Bruce 1984) (Covvey 1981). Several points of access in
electronic information systems allow access to confidential
information. The first is on-site personnel, both
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authorized and unauthorized, who use terminal or dial-up
lines in an 'authorized' manner to obtain and distribute
information improperly. Also obtaining printed information
that has been left unattended (e.g. in waste-paper baskets)
is another on-site means of access to privileged
information. Dial-in lines connected to the computer are
accessible to anyone with modems and terminals. These
lines might be tapped directly, or in extreme circumstances
sensitive electronic receivers might even be used to
remotely decipher the electromagnetic radiation (signals)
generated by poorly shielded computer or communication
equipment. Also, outsiders can 'break in' by trying
various log-in names and passwords until one is found that
works, or by obtaining passwords from authorized persons.
In Britain in 1973 the Medical Research Council formed a
Standing Committee on the Use of Medical Information for
Research. Since the Data Protection Act 1984 these
guidelines have been updated, (Medical Research Council
1985). Some of the recommendations are now reviewed:-
1 Appropriate arrangements should be made and enforced
for adequate physical security of establishments where
confidential medical information is stored and used.
2 Special computing arrangements should be considered
e.g. separation and replacement by code of the
identifying data from the main body of the record or
the use of computer 'scrambler' codes or 'passwords'.
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3 Those responsible for collecting and storing personal
medical data should review at intervals the
desirability of destroying material when its retention
is no longer required.
4 Data of a general statistical nature (i.e. in a form
that prevents identification of individuals) may be
made available to other research workers.
At all times during the course of this study these
guidelines were adhered to.
Entirely as an aside, separate ethical concerns are raised
by the existence of computer-based medical decision making
and programmes capable of providing medical advice directly
to the public. So far there have been no reported cases of
injuries caused by computer soft-ware and it remains
unclear whether liability would be tortious or would arise
through breach of contract. Regardless, principles of
negligence are well established (on both sides of the
Atlantic) and these would apply should a case arise. For
further discussion (United States law) the reader is
referred to Brannigan (1981), Prince (1980) and Lanoue
(1 983) .
3.3 INFORMED CONSENT
During the design of this study, the draft Revised
Procedures on Research Involving Human Subjects, of the
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Medical Research Council of Canada was reviewed. This
study does not appear to raise any special concerns because
of methodology, purpose or subject matter. There are no
potential risks and no new material obtained apart from
routine patient care. Informed consent, therefore, was not
obtained from patients (or their parents/guardians) prior






Much of the methodology referred to in this volume is
common to all the investigations which were undertaken and
in order to avoid needless repetition the more important
methods which were used will be collectively discussed in
this section.
4.1 THE SETTING
The Hospital for Sick Children, Toronto, Canada is a 587
bedded, university affiliated, paediatric hospital which
provides primary, secondary and tertiary care. The
paediatric clinical specialties represented include general
medicine, neonatology, cardiology, neurology,
endocrinology, metabolic disease, immunology, general
surgery, cardiovascular surgery, neurosurgery, orthopaedic
surgery, maxillo-facial surgery, ENT and ophthalmology.
The hospital provides a service for the management of
trauma, burns and acute poisoning and is a regional centre
for liver, kidney and bone marrow transplantation.
There is an 18 bedded PICU which admits approximately 1400
patients per annum with an average daily occupancy rate of
92% and an average daily census of 16.5 patients. (On
occasion during the study, up to 4 beds in the Post
Anaesthesia Recovery (PAR) area were used for patient
care). Patients of all ages up to 18 years are admitted
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with the exception of all premature neonates and neonates
with non-surgical conditions who are admitted to the
Neonatal Intensive Care Unit (NICU).
The following are the criteria for admission into the
PICU:-
a) severe upper or lower respiratory tract distress
demonstrated either solely on clinical grounds or in
association with abnormal blood gas levels, increasing
oxygen requirements, apnoea or altered level of
consciousness.
b) cardiac insufficiency or dysrhythmia requiring close
or precise monitoring.
c) suspected intracranial pathology requiring careful
monitoring.
d) significant alterations of fluid, electrolyte, acid-
base, temperature or coagulation status.
e) post operative state - All infants and children
undergoing cardiac surgery are routinely admitted post
operatively except neonates undergoing uncomplicated
ligation of a patent ductus arteriosus. 40% of
admissions are post operative cardiac surgery
patients. The hospital has a post anaesthesia
recovery area (PAR) which is staffed continuously 24
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hours a day. With regard to all other post operative
patients; as a general rule only those patients
requiring ventilation in the immediate post operative
period are admitted. All patients are admitted post
operatively following liver and kidney
transplantation.
f) another miscellaneous conditions e.g. patients
admitted for investigation of pulmonary hypertension,
patients on home ventilation programme admitted for
sleep studies.
The PICU is situated on the second floor of the hospital
with easy access to the operating theatres, recovery room
and radiology department. The unit occupies a total area
of 5,500 sq.ft., the patient care area accounts for 2,000
sq. ft., (approx. 100 sq. ft., per patient) with the
remaining space devoted to staff offices, storage rooms,
on-call rooms, staff washrooms and a conference room.
During periods of maximum bed occupancy up to 4 'over
spill' beds are available which are sited in the post
anaesthesia recovery room (PAR) immediately adjacent to the
PICU area.
The patient care spaces are divided into 3 four bedded
rooms, one semi-private room with two beds, 3 isolation
rooms with common ante room and one isolation room with its
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own ante room. Each room has one sink. The unit is
naturally ventilated.
The nursing staff provide patient care on a one to one
basis; two clinical instructors and four assistant head
nurses also participate in bed side care. The medical
staff comprises four full time staff intensivists, ten
medical residents and fellows, one anaesthesia fellow and
a psychiatrist. There are no medical students or internes
in the daily health care team. Other ancillary health care
providers who have routine patient care include a
physiotherapist, a respiratory technologist, a radiographer
and a social worker. Consultations are provided in large
numbers daily by fellows and staff in multiple specialties.
Visiting is restricted to immediate family members who are
allowed to visit in groups of two. Children under 12 years
of age are not allowed to visit unless with direct
permission of the nurse in charge. The Hospital for Sick
Children has an Infectious Diseases Department and this
includes an Infection Control Physician and 4 Infection
Control Nurses, one of whom has responsibility for the
PICU. Surveillance results are returned to the Director
and the Head Nurse within four weeks of the end of the
month. There is a PICU Infection Control Committee which
meets quarterly to review surveillance results, new
procedures, policies and occupational health issues. Its
members include the Infection Control Physician and the
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Infection Control Nurse, a staff intensivist, a PICU
Fellow, the Head Nurse, a clinical instructor of nursing
and others by invitation.
An Infection Control Policy has been developed for
physicians and surgeons and is detailed in Appendix 1 .
Specific nursing care procedures have been developed for
surgical handwashing technique, management of intravascular
lines, care of post operative cardiovascular patients, and
prevention of nosocomial conjunctivitis. These are
detailed in Appendices 2-5.
4.2 PATIENTS
During the period 1st July 1987 till 29th February 1988 a
full time Research Fellow trained in critical care medicine
and anaesthesia carried out this prospective study. A
total of 685 patients, admitted consecutively, to the PICU
were studied. Each patient was reviewed by the Research
Fellow daily during the PICU stay and daily for 72 hours
after PICU discharge. The following information was
documented for each patient:-
a) Base-line state
b) The occurrence of nosocomial infection by site and
pathogen
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4.3 DEFINITION OF THE BASE LINE STATE OF THE POPULATION
The base line state of the PICU population was defined
using the following.
a) PAEDIATRIC RISK OF MORTALITY (PRISM) SCORE
b) DEMOGRAPHIC DATA
4.3.1 PAEDIATRIC RISK OF MORTALITY (PRISM) SCORE
The literature on severity of illness scoring (including
the PRISM score) is reviewed in Chapter 2 section 2.3 The
PRISM score on admission to the PICU was derived by
assessing the degree of abnormality of a list of variables
and assigning a score of 1 , 3 or 5 as previously described.
The most abnormal value for each variable was used to
calculate the score. On the day of admission at least 8
hours of data was required, otherwise the data was combined
with the next complete collection interval. Scoring was
done solely by myself using variables routinely documented
by the nursing staff on the PICU flow sheets. The PRISM
scoring system contains age adjusted variables and is
applicable to infants or children. Figure 2 details the
scoring system for children (age >1 year) and Figure 3
details the scoring system for infants (age <1 year).
4.3.2 DEMOGRAPHIC DATA
A specimen data collection sheet is detailed in Figure 4.
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Figure 2 PRISM Score Child
Variable Value Score





Diastolic B.P. >110 6
(mmHg)
Heart Rate >150 4
(beats/min) <80 4







Glasgow Coma Scorec <8 6
Pupils unequal or dilated 4
fixed and dilated 10















Cannot be assessed in patients with intracardiac
shunts or chronic respiratory insufficiency; requires
arterial blood sampling.
May be assessed with capillary blood gases.
Assessed only if there is known or suspected CNS
dysfunction; cannot be assessed in patients during
iatrogenic sedation, paralysis, anaesthesia etc.
Scores <8 correspond to coma or deep stupor.
Use measured values.
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Cannot be assessed in patients with intracardiac
shunts or chronic respiratory insufficiency; requires
arterial blood sampling.
May be assessed with capillary blood gases.
Assessed only if there is known or suspected CNS
dysfunction, cannot be assessed in patients during
iatrogenic sedation, paralysis, anaesthesia etc.
Scores <8 correspond to coma or deep stupor.
Use measured values.
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PICU length of stay (days)
Antibiotic on admission prophylactic Y/N
empirical Y/N
therapeutic Y/N
Steroid on admission Y/N
Immunosuppressant on admission Y/N





The constituents of the demographic data collection sheet
are described in more detail below.
age
hours, days, weeks, months, years,
clinical specialty/underlying disease
a) cardiovascular surgery (includes thoracic surgery
performed by the department of cardiovascular
surgery).









c) trauma - includes burns and electrical shock
d) post-operative other
general surgery - includes liver transplant






e) haematology/oncology - malignant conditions
bone marrow transplants
f) other - a group of miscellaneous unrelated conditions
including:- near drowning,
congenital diaphragmatic hernia.
Length of Stay in PICU
The day of admission was defined as day one and each part
of a day counted as one whole day e.g., admitted on
Wednesday and discharged on Friday would be a PICU stay of
3 days.
Presence of Infection on Admission
Infection developing within 72 hours of PICU admission was
deemed to be "incubating on admission" and infections
present or incubating on admission were not considered to
be PICU nosocomial infection unless they were clearly the
result of a previous PICU admission.
Infection incubating on admission or already present on
admission was considered to be either
1 ) hospital acquired - ward area of the Hospital for Sick
Children or some other hospital.
2) community acquired






For viral infection the following incubation periods were
used (Valenti 1980):-
Upper Respiratory







unknown aetiology >3 days
Norwalk like >2 days
salmonellosis >2 days
rota virus >3 days
Campylobacter sp. >3 days
shigellosis 1 -7 days
When it was unclear if an infection was PICU acquired or
hospital acquired/community acquired then the infection was
not considered to be PICU acquired.
Pre-admission steroid therapy






Antibiotics were further classified as:-
a) prophylactic
b) empirical (best bet, microbiologic sensitivities not
available)
c) therapeutic (rational choice, microbiologic
sensitivities available)
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4.4 DOCUMENTATION OF NOSOCOMIAL INFECTION




























The presence of each therapeutic device was noted along
with its duration of use. When a device was removed it was
recorded whether removal was because of infection or for
some other reason e.g., no longer functional, no longer
required.
Re-insertion of devices was documented. A coding system
was used:-
P=device present;
X=device removed; (for reason other than infection)
S=device resited; (after removal for reason other
than infection)
I=device infected;
R=device infected and removed;
A=device resited; (after removal because of infection)
arterial lines
Arterial lines were identified by anatomical site of
insertion:-
peripheral artery - hand or foot
(radial, ulnar, dorsalis pedis, post, tibial)
arm - brachial artery
groin - femoral artery
umbilical artery
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Central venous Lines were identified by anatomical site of
insertion:-
neck - jugular or subclavian vein,
arm - basilic or cephalic vein,
groin - femoral vein,
umbilical vein




surgical insertion with sub-cutaneous tunnelling
intracranial pressure monitoring device
bolt or catheter
chest or pericardial drain
peritoneal drain
includes peritoneal dialysis catheter
other cavity drain e.g., Jackson Pratt drain
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4.5 SURVEILLANCE FOR NOSOCOMIAL INFECTION (case finding)
Definition of Bedside Observation
The Research Fellow undertook bedside observation a minimum
of six days per week which comprised
selective clinical examination of patients,
review of PICU flow charts,
questioning of nursing staff,
review of medical and nursing notes,
review of microbiology reports,
review of other pertinent investigations e.g.,
tissue biopsy,
review of chest xrays - these are reported 5 days
per week by one PICU dedicated radiologist,
review of drug Kardex,
in the event of death and autopsy - review of
autopsy report and if possible attendance at the
autopsy.
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4.6 DEFINITIONS OF INFECTION
The following definitions of infection were used:-
Bacteraemia
positive culture of any organism, rule out contaminant




2. Vascular Line Related (arterial and central venous line)
Levels of evidence of infection in decreasing order of
significance were:-
1 ) positive line blood culture + one or more positive
peripheral blood cultures,
2) positive line tip + one or more positive peripheral
blood cultures,
3) positive line tip + one or more positive line blood
cultures,
4) positive line tip + positive culture from line exit
site,
5) positive line blood culture + positive culture from
exit site,
6) positive culture from exit site + positive peripheral
blood culture,
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7) compatible clinical situation with no other source +
two positive blood cultures,
8) compatible clinical situation with no other source +
one positive blood culture,
9) compatible clinical situation with no other source +
positive culture from exit site,
10) compatible clinical situation with no other source +
positive culture of line tip,
11) vascular line blood only,
12) CVL blood + arterial line blood only (no peripheral
sample).
Respiratory
Organisms cultured from aspirates of endotracheal tubes or
tracheostomies were not considered evidence of infection.
In a very small number of patients aspirate from direct




otitis media:- fever and red or bulging ear





Clinical diagnosis by ward staff in collaboration with the
infection control service for which microbiologic
confirmation is not essential.
Lower Respiratory
The definition of infection used was:-
a) infiltrate - on chest xray,
not present on admission,
not attributable to a non infectious cause
b) plus or minus microbiological confirmation,
In difficult cases a consensus decision was made by the
attending PICU physician and the staff radiologist.
Gastrointestinal
Two loose stools in 24 hours with or without identification
of virus on electron microscopy / postive bacterial
culture. Clinical picture must be compatible and other
entities must be ruled out.
Necrotising colitis diagnosis requires clinical and xray
features +/- positive C. Difficile blood titre.
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Eye




oedema of the eyelid
or,
hyperaemia of the inferior palpebral
conj unctiva,
2) Endophthalmitis / corneal opacification.
Skin
Most cutaneous sites were diagnosed by clinical criteria
- pus in skin or subcutaneous tissue +/- positive culture
of pathogen. This group included skin infection at the
entry sites of devices e.g., drains, vascular lines.
NOTE If skin infection of a vascular line entry site was
accompanied by other features of vascular line infection







<30 days since surgery
>30 days since surgery
Endocarditis Non-Surgical
No previous cardiovascular surgery,
Post operative Wound
1. Post operative wound (excluding sternal wound)
This required clinical evidence of infection i.e.,
surrounding erythema +/- purulent drainage at wound site
+ /- microbiological evidence.





infection limited to skin and
soft tissue overlying the
sternum +/- bacteraemia.
<30 days since surgery,
infection extending to the
sternum and/or mediastinal
contents, +/- bacteraemia.
<30 days since surgery,
as above, >30 days since
surgery.




All samples were obtained via a urinary catheter either
indwelling or intermittent or from supra pubic bladder
aspiration. 'Clean catch' specimens were not used to
diagnose urinary infection. Infection was diagnosed when
there were >100,000 colonies per ml. urine of any organism.
Chest Drain
Positive culture of either fluid or drain tip after drain
removal (under strict aseptic conditions).
Note: infection at the chest drain entry site was
classified as skin infection.
Peritoneal Drain (including Dialysis Catheter)




Positive CSF culture or latex agglutination - no previous
neurosurgery.
Secondary
Positive CSF culture or latex agglutination - previous
neurosurgery including insertion of intracranial pressure
(ICP) monitoring device or an external ventricular drainage
device (EVD).
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4.7 EXPRESSION OF NOSOCOMIAL INFECTION RATES
The nosocomially infected patient ratio (NIPR) was
calculated by obtaining the number of patients who acquired
one or more infections and dividing by the number of
patients admitted to the PICU x 100. The nosocomial
infection ratio (NIR) was calculated by obtaining the total
number of infections divided by the total number of
patients admitted to the PICU x 100.
4.8 STATISTICAL ANALYSIS
Throughout the study several statistical methods were used
as indicated. These include the two tailed Fisher exact




NOSOCOMIAL INFECTION IN A PAEDIATRIC INTENSIVE CARE UNIT:
INCIDENCE AND USE OF THE PRISM SCORE AS A PREDICTOR.
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NOSOCOMIAL INFECTION IN A PAEDIATRIC INTENSIVE CARE UNIT:
INCIDENCE AND USE OF THE PRISM SCORE AS A PREDICTOR.
SUMMARY
Between July 1987 and February 1988, all patients admitted
to the Paediatric Intensive Care Unit (PICU) were
classified using the PRISM score and followed, for the
development of nosocomial infection, by a full time
Research Fellow trained in intensive care medicine.
Variables including clinical specialty, age, and PICU
length of stay were identified.
During the study period 685 patients were admitted; 48
patients developed 100 nosocomial infections (7 infected
patients per 100 patients admitted; 14.6 infections per
100 patients admitted). Patients with PRISM scores »10 on
admission were significantly more likely to acquire
infection than those with scores <10 ( 10.8% v, 3.4%,
p <0.001). This association held through age, clinical
specialty and length of PICU stay. The sensitivity,
specificity, positive and negative predictive values of a
PRISM score >10 were 75%, 53%, 11% and 97% respectively.
As a percentage of total infections, bacteraemias accounted
for 36% skin/eye/drain site infections for 22%, respiratory
infections for 16%, wound infections for 15%, and urinary
tract infections for 9%.
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As a percentage of organisms causing infection, the most
prevalent pathogens were coagulase negative staphylococci
(CONS) (32%), Pseudomonas aeruginosa (23%), Candida sp.
(20%) and S. aureus (9%).
A PRISM score >A 0 on admission to the PICU characterizes a
population within the PICU at increased risk of infection.
However, 93% of patients did not develop infection and thus




Nosocomial infection rates vary widely among different
types of Intensive Care Unit, from 1% in cardiac surgical
units to 25% or greater in medical, surgical and neonatal
units. (Northey 1974) (Thorp 1979) (Chandrasekar 1986)
(Hemming 1976) (Daschner 1982).
There are few data providing rates in the paediatric ICU
(Brown 1987) (Donowitz 1982, 1986b) (Welliver 1984)
(Milliken 1988) (Jarvis 1987, 1988) and rates in neonatal
ICUs have sometimes been presented as PICU rates (Massanari
1986). Among published reports, the incidence of
nosocomial infection has ranged from a low of 3.0% in a 3
bed unit (Donowitz 1982) to 24.1% (Jarvis 1988). A
previous study has been undertaken in this PICU (Hospital
for Sick Children, Toronto), based on twice-weekly chart
review plus review of microbiology reports 5 days per week
performed by two Infection Control nurses. Over a period
of 30 months, 116 infections occurred in 1,388 patients who
remained in the PICU for a minimum of 72 hours (6.1
infections per 100 admissions) (Milliken 1988).
A limitation of all the studies, performed to date, is the
failure to adequately describe the baseline state of the
population to enable comparison between institutions or
within institutions over time. A severity of illness
scoring system, the Physiologic Scoring Index (PSI) has
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been validated as a predictor of mortality in the PICU (Yeh
1984) (Pollack 1987a, 1987b) and has recently been adapted
to a shorter version - the PRISM score. (Pollack 1987c,
1 988) .
The aim of this study was to characterize the PICU
population by PRISM score on admission as well as other
traditional demographic data; to document the incidence of
nosocomial infection by site and clinical pathogen in this
group, and to report the use of the PRISM score as a
predictor for the development of nosocomial infection.
5.2 METHODOLOGY
5.2.1 General
The study was performed using the general methodology
described in Chapter 4. Patients were characterized by
certain demographic data as well as PRISM score on
admission and were reviewed daily for the development of
nosocomial infection while in the PICU and for 3 days after
discharge. Nosocomial infections were described by site
and clinical pathogen using the criteria for infection,




The nosocomial infection rate was calculated as the number
of nosocomially infected patients per 100 patients admitted
during the 8 month study period. Specific nosocomial
infection rates were calculated for subgroups of patients
based on the admission PRISM score, length of PICU stay,
age and clinical specialty.
Chi-square analysis was used to compare the infection rates
of patients with high and low PRISM scores. The Mantel-
Haenszel procedure was used to compare infection rates in
the two PRISM groups across the levels of a third grouping
variable. Sensitivity, specificity, predictive values and
power were calculated using standard methods.
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5 . 3 RESULTS
During the eight month period, 685 patients were admitted
to the PICU of whom 480 remained for 48 hours or more. 16
patients (2.3%) were admitted with nosocomial infections
acquired in HSC or elsewhere (in another referring
hospital) and 40 patients (5.8%) were admitted with a
community acquired infection. While in the PICU, a total
of 48 patients (7%) developed 100 nosocomial infections (15
infections per 100 patients admitted). 130 patients
(19.0%) were receiving empiric or therapeutic antibiotic
therapy on admission; 378 (55.2%) were receiving
prophylactic antibiotic therapy on admission, reflecting
the high proportion (69%) of trauma patients and post
operative surgical patients (cardiac surgery and other
surgery). 17 patients (2.5%) received steroid therapy
prior to admission and 12 patients (1.8%) received immuno¬
suppressive therapy prior to admission.
The population is characterized by PRISM score in Table 3;
there were equal proportions of patients with PRISM scores
<10 and PRISM scores >10.
Table 4 shows the frequency of nosocomial infection by
PRISM score; significantly more infections were acquired in
the PICU by patients with PRISM score >10 (35/333) than by
those with PRISM score <10 (12/352); (10.8% vs 3.4%;
p <0.001).
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Table 3 Proportional frequency of PRISM scores









10 - 14 1 97 28.8
15 - 19 71 10.3
20 - 24 35 5.4
25 - 29 14 2.0
>30 1 6 2.3
TOTAL 685 100.0
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PRISM < 1 0 PRISM>/1 0
26 1 8
11
TOTAL 48 1 2 36
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Table 5 shows the infection rates by PRISM score and length
of stay in the PICU. PRISM score was significantly
associated with length of stay (p <0.001) accounting for
much of the relationship of PRISM with infection rate.
However, the predictive relationship of PRISM score and
infection is apparent in longer PICU stays. For the
Mantel-Haenszel procedure, length of stay categories >16
days were combined because of small numbers. The Mantel-
Haenszel summary chi-square was not significant (p = 0.10)
across all 4 length of stay groups, but was significant
when only those with length of stay 7 days or more were
analyzed (p <0.02).
The relationship between PRISM score y1 0 and increased risk
of nosocomial infection is demonstrable across age ranges
(Table 6). The increased nosocomial infection rate with
PRISM score >/10 was observed throughout all clinical
specialties (Table 7).
1 46
Table 5 Relationship of PRISM score and length of stay in
PICU to nosocomial infection rate
PICU stay Total PRISM <10 PRISM yi 0
(days) n % inf n no.inf % inf n no.inf % inf
<7 551 2.2 308 6 2.0 243 6 2.5
7 - 1 5 1 06 1 4.2 37 4 1 0.8 69 1 1 1 5.9
16-24 18 61.1 6 1 16.7 12 10 83.3
25-35 3 100.0 0 0 - 33 100.0
>35 7 100.0 1 1 100.0 6 6 100.0
TOTAL 685 7.0 352 12 3.4 333 36 10.8
n = number of patients
% inf = percentage of n who were infected
no.inf = number of patients within each PRISM group
who were infected.
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Table 6 Relationship of PRISM score and age to nosocomial
infection rate
Patient Total PRISM <10 PRISM >10
age n % inf n no.inf % inf n no.inf % inf
<30 days 62 1 1 .3 1 3 1 7.7 49 6 1 2.2
31-180 days 88 11.4 38 0 0 50 10 20.0
6 mo-2 yr 122 7.4 63 3 4.8 59 5 8.5
2-10 yr 273 6.2 143 6 4.2 130 10 7.7
>10 yr 140 3.6 95 2 2.1 45 5 11.1
TOTAL 685 7.0 352 12 3.4 333 36 10.8
n = number of patients
% inf = percentage of n who were infected
no.inf = number of patients within each PRISM group
who were infected.
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Table 7 Relationship of PRISM score and clinical specialty
to nosocomial infection rate
Clinical Total PRISM <10 PRISM >/\0
speciality n % inf n no.inf % inf n no.inf % inf
trauma 55 3.7 28 0 0 27 2 7.4
postop
cardiac 314 9.4 138 9 6.5 176 21 11.9
postop
other 106 2.8 66 0 0 40 3 7.5
oncology 1010.0 5 0 0 5 1 20.0
medical 169 6.5 99 3 3.0 70 8 11.4
other 31 3.2 16 1 6.2 15 0 0
TOTAL 685 7.0 352 13 3.6 333 35 10.5
n = number of patients
% inf = percentage of n who were infected




Two patients had 6 infections, 5 patients had 5 infections,
1 patient had 4 infections, 3 patients had 3 infections, 11
patients had 2 infections and 26 patients had one infection
each. Of the 36 infected patients with PRISM scores >10,
18 (50%) had more than one infection compared to 4 (33%) of
12 infected patients with PRISM score <10 (p >0.5).
Deaths
The overall mortality rate in the unit was 8.8% (60/685)
with deaths in 8.5% of patients without nosocomial
infection (54/637) and deaths in 12.5% of patients with
nosocomial infection (6/48) (p >0.5). This suggests that
overall nosocomial infection rate does not increase
mortality, although the power to detect a difference is
low. Of those with PRISM scores <10, 11 (3%) died, of
those with PRISM scores >10, 58 (17%) died (p <0.001).
Thus PRISM >1 0 predicts both mortality and nosocomial
infection, but infection does appear to be directly related
to infection.
Site of Infection
The relative frequency of nosocomial infection by site and
PRISM score is listed in Table 8. It appears that the
nosocomial infection rate from bacteraemia (all types) was
higher in PRISM scores >10 but it is suspected that high
score patients had more vascular lines and therefore were
at greater risk of bacteraemia.
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Table 8 Relative frequency of nosocomial infections by site
and by PRISM score








Blood 12 1 .8 5 1 .4 7 2.1
CV Line 1 2 1 .8 2 0.6 1 0 3.0
Art line 12 1 .8 3 0.8 9 2.7
Resp.upper 6 0.9 3 0.8 3 0.9
Resp.lower 1 0 1 .5 3 0.8 7 2.1
Postop wound 1 5 2.2 2 0.6 1 3 3.9
Urine 9 1 .3 0 0.0 9 2.7
Skin 7 1 .0 2 0.6 5 1 .5
Chest drain 5 0.7 1 0.3 4 1 .2
Peritoneal
drain 4 0.6 0 0.0 4 1 .2
Eye 5 0.7 2 0.6 3 0.9
SBE 1 0.1 0 0.0 1 0.3
T tube 1 0.1 1 0.3 0 0.0
Gastrointest. 1 0.1 0 0.0 1 0.3
TOTAL 1 00 14.6 24 6.8 76 22.8
No Inf = number of infections
NIR = Infections/100 admissions = Nosocomial
Infection Rate
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Patients with low PRISM scores were at risk from
bacteraemias and respiratory infections while those with
high PRISM scores had higher rates at virtually all sites
including post operative wound infections. Bacteraemias
and other line related infections accounted for 36% of
infections; respiratory wound and skin/chest/peritoneal
drain for approximately 15% each; urine 9%; eye 5% and
other 3%. Seventy six of these 100 infections were in
patients with PRISM ^10 and this proportion was consistent
across sites.
The relative frequency of organisms causing nosocomial
infection is detailed in Table 9. Gram positive, gram
negative bacteria and fungi accounted for 42%, 35% and 19%
of infections respectively.
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Table 9 Relative frequency of organisms causing nosocomial
infection
No. Proportional %


























Experience with intravascular lines
Vascular line related infections were analyzed in terms of:
the anatomical site of line placement, the method of line
placement (surgical v percutaneous), the level of evidence
for infection, the organisms causing infection and the
length of time the line was in situ prior to infection.
Levels of evidence for infection are detailed in Chapter 4,
section 6; Criteria for Infection, vascular line related.
Central venous lines
In total 300 central venous lines were placed; infection
occurred in 12 lines (4%). Lines were surgically placed
(using a subcutaneous tunnel) in 21 cases (1 infection;
5%), otherwise, in 279 cases, lines were placed
percutaneously (11 infections 3.9%). No infections
occurred in 2 umbilical lines. Infections occurred in 1 of
21 tunnelled neck lines (5%), in 8 of 227 non tunnelled
neck lines (3.5%), in 2 of 16 arm lines (12.5%) and in 1 of
34 femoral lines (2.9%). Table 10 details infected central
venous lines.
Arterial lines
In total 494 arterial lines were placed; infection
occurred in 12 lines (2.4%). Lines were surgically placed,
using a cut down in 68 cases (2 infections, 2.9%).
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Otherwise lines were placed percutaneously (426 cases 10
infections, 2.3%). No infection occurred in 5 umbilical
lines or in 1 arm (brachial) line. Two infections occurred
in 45 femoral lines (4.4%) and 10 infections occurred in
443 lines placed peripherally, in either the hand or the
foot (2.25%). Table 12 details infected arterial lines.
Extended use of Lines
25% of arterial lines and 30% of percutaneous central lines
are in situ >5 days. Arterial lines in situ >5 days are
more likely to be infected (3/300 vs 9/119 or 1.0% vs
8.3%). Similarly, percutaneous CVLs in situ >5 days are
more likely to be infected (9/75 vs 3/225 or 12% vs 1.3%).
Concurrent Infected lines
In 3 of 12 situations in which either arterial or central
line cultures were positive, both arterial and central
lines were culture positive.
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Table 10 Central venous line related nosocomial infections
site n no.inf % inf organism level of line day
evidence* of inf**
tunnel 21 1 5.0 PA 1 7
neck
arm 16 2 12.5 diptheroids 8 4
haem strept 10 13
non 227 8 3.0 dipth/CONS 1/5 12/35
tunnel Candida alb 1 11
neck SA 23
PA/E cloac 9 11
Candida alb 3 8
PA/CONS 9/2 9
Candida para 9 8
haem strept 10 4
femoral 34 1 2.9 ent strept/ 9 5
Candida alb
umbilical 20
TOTAL 300 12 4.0
**
level of evidence of infection see Section
4.6 - definitions of infection, vascular
line related infections
line day of inf = day when line was first
infected (day of line placement = day 1)
Candida alb = Candida albicans
Candida para = Candida parapsilopsis
PA = pseudomonas aeruginosa
S A = staphylococcus aureus
CONS = coagulase negative staphylococci
haem strept = haemolytic streptococci
ent strept = enteric streptococci
dipth = diptheroids
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Table 11 Arterial line related nosocomial infections
site n no.inf % inf
femoral 45 2 4.8
periph 443 10 2.3
umbil 5 0
arm 1 0
organism level of line day
evidence* of inf**











cand alb 11 11
TOTAL 494 12 2.4
* level of evidence of infection - see Section
4.6 - definitions of infection, vascular
line related infections
** line day of inf = day when line was first
infected (day of line placement = day 1 )
P P = pseudomonas putida
S A = staphylococcus aureus
CONS = coagulase negative staphylococcus
cand alb = Candida albicans
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5.4 DISCUSSION
These data further define the epidemiology of nosocomial
infections in the PICU by describing more precisely the
baseline state of the study population. They lend
additional support to the validity of the PRISM scoring
system as a predictor of nosocomial infection as well as
death. While the inter-relatedness of PRISM score and
length of stay complicates interpretation of the study, it
should be noted that the PRISM score identifies high risk
patients on admission, rather than later in the stay. It
is not clear whether risk of infection is a cause or effect
of the high PRISM score. Preventive interventions, e.g.,
gown and gloves, might be of use in this specific high risk
group. Possible intervention strategies, which may be
applied to high risk patients, are discussed further in
Chapter 9. Use of the PRISM score should be encouraged to
characterize PICU patients and their risk of infection for
comparative purposes. An alternative scoring system might
be the Therapeutic Intervention Scoring System (TISS) which
determines how much actual medical intervention is needed
for each patient (see Chapter 2 section 3.5) although, it
does not offer the additional benefits, provided by the
PRISM system, unrelated to infectious diseases (Pollack
1988).
The sensitivity and specificity of a PRISM score £,10 were
75% and 53% respectively. Paediatric patients with PRISM
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scores >,,10 on admission to the PICU have a significantly
greater risk of nosocomial infection despite differences in
age and length of stay. The positive and negative
predictive values of the PRISM score were 11% and 97%;
thus those patients with a PRISM score <10 were unlikely to
become infected. If the PRISM score were to be used as a
"test" for whether or not a patient would later develop
nosocomial infection, this report suggests it would have a
sensitivity of 75%; that is, 75% of those with infection
would be in the group with high PRISM scores.
Unfortunately, the positive predictive value would be only
11%; that is, only 11% of those identified by their high
admission PRISM score would later develop infection. The
specificity of this test might be expected to be 53%; that
is, of patients who do not become infected 53% would be
found in the low PRISM group. The negative predictive
value, 97%, means that the test is correct 97% of the time
when it predicts that a patient will not become infected on
the basis of a low PRISM score. It should be noted that in
the study group overall, 93% of patients did not become
infected, so guessing that nobody would become infected,
would have a negative predictive value of 93%.
Nevertheless, the admission PRISM score does characterize
patients at higher risk of infection.
Reports of nosocomial infection in PICU patients have
varied widely. (Welliver 1984) (Donowitz 1986b) (Brown
1987) (Milliken 1988) (Jarvis 1988). Previously measured
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variables which may contribute to this are: differing size
of the units; differing patient populations as measured by
the percentage of patients admitted with nosocomial
infection and the percentage of patients admitted with
nosocomial infections acquired elsewhere in the hospital;
differing proportions of patients in terms of clinical
specialty, and differing mortality rates.
Definitions of nosocomial infection have been fairly
consistent. Previously unmeasured variables include the
intensity of surveillance, the application of diagnostic
tests, baseline state of the population or underlying
illnesses, as well as environmental and behavioural
features such as education about, and compliance with,
infection control policies for all full time and rotating
staff.
In a previous study, performed in 1988 in this PICU (HSC,
Toronto), Milliken documented differences among patients'
risk of infection by age and by length of stay prior to the
onset of the first nosocomial infection (Milliken 1988).
Patients in the first two years of life, particularly those
aged 7 to 30 days, have the highest rates of infection.
Onset of infection was more common after the first week in
the PICU with infections acquired by 1 1 % of patients
staying 14-20 days; 27% of patients staying 21-27 days;
48% of patients staying 28-34 days, and 52% of patients
staying more than 35 days. The present study further
1 60
refines this finding by adjusting for PRISM score (Tables
5 and 6). Whether the global increase in infection since
the 1983-85 report is due to improved intensity of
surveillance (i.e., daily bedside review by dedicated
Research Fellow/intensivist vs twice weekly chart review,
lab reports) or other unmeasured factors is unclear. It is
suspected that the current patient population is
substantially sicker as new operative procedures,
(particularly cardiac) requiring post operative PICU care
are introduced and the use of indwelling intravascular
lines is increased.
There are few data with which to compare the results of the
present study. The work does confirm Milliken's earlier
finding that viral disease is occurring at a far lower
incidence in the PICU than in other parts of the Hospital
for Sick Children where, for example, 8 to 10% of infants
and young children acquire viral diarrhoea. (Ford-Jones in
press). Unmeasured differences, which might explain this,
are: less exposure to staff through one to one nursing
ratios; fewer staff caring for infected and uninfected
children; less visitors including siblings; personalized
equipment and absence of child to child contact.
Furthermore, patient hand/mouth contact is not possible.
Published data on pathogens are similarly sparse. This
study demonstrates that gram positive pathogens are
slightly more common than gram negative (42% vs 35%) and
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viral pathogens are extremely uncommon. Of concern, is
the increasing proportional frequency of fungal pathogens
to 20% of the total; this reflects published experiences
that fungal nosocomial infections are on the increase.
Vascular line related infections have been analyzed in
terms of site and method of placement. In the PICU,
culturing of indwelling vascular lines presents problems,
for example: inotropic agents being administered via
central venous lines cannot be stopped for the duration of
a culture without risk to the patient; meticulous
culturing of multilumen catheters, with appropriate
labelling of the ports may not be carried out.
It is routinely taught that to accurately diagnose catheter
related bacteraemia, (as opposed to catheter colonization
alone), simultaneous sampling of blood from a peripheral
vein and from the vascular line should be performed.
However, evidence for this presumption is somewhat scarce.
Two studies (Tonneson 1976) (Felices 1979) refute the
dictum and Holzman (1981) concludes that if the injection
port of the catheter is properly cleaned with an agent
containing iodine-povidone, valid cultures may be obtained
via this route. Ideally, the completeness of culturing
during a possible septic event should be recorded.
2.4% of arterial lines were infected; risk of infection
increased with duration of catheter use but did not seem to
be increased either by surgical cut down (cut down 2.9%
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infected vs percutaneous 2.3% infected) or by insertion of
lines in the groin. This compares with the results of a
study of 130 arterial catheters by Band et al (1979) who
reported a 4% incidence of line related sepsis and an
increased risk of infection in association with both
increasing duration of catheterization and placement of the
catheter by means of surgical cut down. Adams (1980)
reported catheter related sepsis in only 0.6% of radial
artery catheters in new born infants, but mean duration of
catheter placement was 48 hours or less. In this study,
there was a preponderance of infection with coagulase
negative staphylococci (83% cases); one line had a
simultaneous infection with pseudomonas putida, an organism
which is usually assumed to be a contaminant.
With regard to central venous lines; 4% of lines became
infected which is in accordance with the observations of
Maki (1973). Risk of infection increased with duration of
catheter use and siting central venous lines in the ante
cubital fossa but there was no apparent increase associated
with the siting in the groin. It should be noted that
numbers in the ante cubital fossa and groin groups were
very small and conclusions should be guarded. CVL
infections were caused by a wider range of organisms,
though most were skin flora organisms (CONS, diptheroids).
It has been observed previously that intravascular lines
commonly are colonized by organisms of the skin flora (Maki
1973) (Crossley 1972) (Peter 1972) (Collins 1968) (Fuchs
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1971). In the present study, Candida species accounted for
infection in 4 cases (33%). Maki (1973) reported infected
central venous lines in 27% of patients with Candida and
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EARLY NOSOCOMIAL INFECTION IN PAEDIATRIC CARDIAC SURGERY
PATIENTS
Focus on Operative Procedure and the Intensive Care Unit
SUMMARY
All patients who underwent cardiac surgery and were
admitted to the Paediatric Intensive Care Unit (PICU)
between July 1st 1987 and February 29th 1988 were reviewed:
1 ) for nosocomial infection at all sites - daily and
for 72 hours after discharge from the PICU
2) for wound infection - for 2 months after surgery.
Patients were characterized by surgical procedure and PRISM
score on admission to the PICU.
During the study period 310 patients were admitted. 40
patients (nosocomially infected patient ratio (NIPR) =
12.9%) developed 78 infections (nosocomial infection ratio
(NIR) = 25.2), of which 28% were wound infections occurring
within two months of surgery (n = 22). Early wound
infection followed 8.0% of closed (non cardio-pulmonary
bypass (non CPB)) cases and 6.7% of open (cardio-pulmonary
bypass (CPB)) cases.
Wound infection was more likely if the sternum was open
post operatively, while in the PICU (27.6% open sternum v
5.0% closed sternum p = 0.00028); if the PRISM score on
1 66
admission was >/l 0 (10.7% >10 v 2.3% <10; p = 0.00344), and
following specific surgical procedures.
The causative agents in wound infections in closed (non
CPB) cases were Staphylococcus aureus (70%) and coagulase
negative staphylococci (CONS) (30%) while in open (CPB)
cases they were CONS (33%), P. aeruginosa (27%), Candida
sp. (27%) and Staph aureus (20%).
Non-wound infections accounted for 72% of infections
(n=56). The number of bacteraemias and other central
venous line and arterial line related infections
approximated wound infections in incidence at 6.8
infections per 100 patients.
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6.1 INTRODUCTION
Wound infections occurring in paediatric cardiac surgery
patients have been reported (Edwards 1983) (Culliford
1976), however infections have not been stratified
previously either by operative procedure or by the status
of the patient at the time of surgery. Furthermore,
despite the introduction of complex intravascular
monitoring devices, the incidence of non wound infections
in paediatric cardiac surgery patients has not been
formally documented. This study reports
1) nosocomial infections at all sites occurring in
a population of paediatric cardiac surgery
patients in the PICU.
2) early wound infections occurring within the first




The study was performed in the setting, using the common
methodology as described in Chapter 4.
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6.2.2 Definition of population by surgical procedure
In addition to definition of the population by PRISM and
demographic data, all patients were identified by type of
surgical procedure (see Appendix 5 for procedures) and
whether or not the sternum remained open in the post
operative period. Patients where the sternum remained open
post operatively were further divided into those where the
sternum was electively left open at the time of surgery
(delayed sternal closure) and those where the sternum was
closed at the end of the surgical procedure and then
subsequently required re-opening as an emergency procedure
in the PICU. In this population, delayed sternal closure
is usually undertaken when myocardial oedema precludes
closure and emergency opening of the sternum is usually
undertaken for management of suspected cardiac tamponade.
6.2.3 Cardiac Surgery Protocol
General
All infants and children who undergo cardiac surgery are
admitted to the PICU in the immediate post operative period
except neonates undergoing ligation of an uncomplicated
patent ductus arteriosus who are returned to the Neonatal
Intensive Care Unit (NICU).
The operative team comprises staff, Fellows and Residents
169
in Cardiovascular Surgery and Anaesthesia. Observers and
students from multiple disciplines may be present.
Children undergo a chlorhexidine bath the evening before
elective surgery; the pre-operative patient care scrub
consists of a 5 minute application of povidone iodine
(Ford-Jones 1988). At induction of anaesthesia
prophylactic cefazolin is administered intravenously in a
dose of 40mg/kg body weight up to a maximum total dose of
750 mg. After establishment of cardiopulmonary bypass 40
mg. of cefazolin per 250 mis of prime solution are added to
the pump. Post operatively the dose of antibiotic given at
induction of anaesthesia is administered intravenously
commencing 6 hours after the first dose and continuing
every 6 hours to a total of 9 doses. In the case of
penicillin allergy, vancomycin is given at induction of
anaesthesia (but it is not used in the pump solution).
If a chest tube is in situ, or if the sternum remains open
in the post operative period (either electively or
following emergency re-opening), antibiotic is continued
until the chest tube is removed or the sternum is closed.
For children undergoing delayed sternum closure gentamicin
2mg/kg (max total dose 120mg) is also given 1 hour before
sternum closure and every 8 hours thereafter for 72 hours.
Dressings on chest tubes and open sternotomy wounds include
a sterile waterproof bandage (Surgihesive, Squibb(R),
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Montreal Canada) for 3 days followed by transparent
semipermeable membranes (Opsite(R)) for 4 days if the child
stays in the PICU. A closed sternotomy wound is left
uncovered. Chest drains and pacemaker wires are removed
aseptically. PICU policy with respect to dressings and
care of incision site, pacemaker wires, chest tube sites
etc. is detailed in Appendix 3.
Intravascular Lines
Most intravascular lines are placed while in the operating
room as a sterile procedure either percutaneously by
anaesthetists or by surgeons by means of a cut down.
Arterial lines are placed in the radial, femoral or
dorsalis pedis arteries. Percutaneous central venous lines
are placed in the internal jugular, subclavian, basilic or
femoral veins. Umbilical lines inserted in the neonatal
intensive care unit (NICU) are not used for monitoring.
Intravascular Lines are maintained as per PICU policy based
on CDC guidelines - see Appendix 2. Policies with respect
to arterial line and central venous line dressings are
detailed in Appendix 2.
Measurement of Cardiac Output
Pulmonary artery flotation catheters (Swan-Ganz catheters)
are not routinely used in cardiac surgery patients.
Cardiac output is routinely measured using the indocyanine
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green method. Dye is usually injected into a central
venous line and blood is sampled via the arterial catheter.
In certain circumstances direct right atrial (RA), left
atrial (LA) or pulmonary artery (PA) catheters may be left
in situ post operatively.
Fluids/Nutrition
Initial fluid management at 75% maintenance during
ventilation includes crystalloid and blood products as
required. Nasogastric feeds are resumed as soon as
possible. Total parenteral nutrition is reserved for
children deemed to require a high calorie intake or those
who have intolerance of nasogastric feeds after more than
5 days.
6.2.4 Patient Follow-up
All patients were followed, by the Research Fellow, for
development of wound infection and infection at other sites
during their stay in the PICU and for 72 hours after
transfer to the open cardiology ward as per general
methodology. In addition patients were followed for at
least two months for the development of wound, chest tube
and pace-maker wire site infections. This follow-up was
carried out by the Infection Control Nurse.
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6.2.5 Data Analysis
The nosocomially infected patient ratio (NIPR) was
calculated by obtaining the total number of patients who
acquired one or more infections following cardiac surgery
by the number of patients undergoing surgery and admitted
to the PICU x 100.
The nosocomial infection ratio (NIR) was calculated by
obtaining the total number of infections following cardiac
surgery by the number of patients undergoing surgery and
admitted to the PICU x 100. The proportion of infected and
uninfected patients was compared using the two tailed
Fisher exact test. The information was not computerized in
a manner which allowed for multiple correlation analysis.
6.3 RESULTS
Three hundred and ten patients underwent cardiac surgery
between July 1st 1987 and 29th February 1988. The wound
infection ratio was 12.9 and the NIR was 25.2. The wound
infection ratio was 8.0 for patients undergoing closed (non
cardio-pulmonary CPB) surgery and 6.7 for those undergoing
open (cardio-pulmonary CPB) surgery - see Table 12.
Of 87 patients undergoing closed (non CPB) surgery, 11
patients developed 7 wound infections and 7 non wound
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infections (1.3 per patient). Of 223 patients undergoing
open (pump) surgery, 29 patients developed 15 wound
infections and 49 non wound infections (2.2 per patient).
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Table 12 Incidence of post operative wound infection by
category of cardiac surgery (open or closed)
Total no Open Closed
of procedures
No patients 310 223 87
No wound infections 22 15
Incidence wound infections 7.1 6.7 8.0
No wound infections 56 49
Total incidence infections 25.2 28.7 16.1
Open (cardiopulmonary bypass (CPB) ) and closed (non
cardiopulmonary bypass (non-CPB) ) cardiac surgery
procedures are defined in Appendix 6.
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6.3.1 Characteristics of Infections Following Closed (Non-
CPB) Surgery
A total of 87 patients underwent closed cardiac surgery.
Condition as measured by the PRISM score at the time of
admission to the PICU after Surgery included 55% with a
PRISM score <10 and 45% with a PRISM score >10.
Infection at all sites
Of the patients with a PRISM score <10 8.3% (4/48)
developed infections at any site. Of the patients with a
PRISM score >10 17.9% (7/39) developed infections at any
site (p >0.05. NS). Infections included four bacteraemias
(two of unknown aetiology; one secondary to a tunnelled
central line; and one secondary to an arterial line) of
which three were caused by coagulase negative staphylococci
and one was caused by Pseudomonas aeruginosa. The other
three infections were at the following sites : eye (Strept.
viridans), skin (P. aeruginosa), and chest tube site (no
isolate). These infections had a mean onset of 6.1 days
post operatively (median 6 day).
Wound Infection
Of the patients with PRISM scores <10, 6.3% (3/48)
developed wound infections compared to 10.3% (4/39) of
patients with a PRISM score >10 (p >0.05. NS). The
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incidence of post operative wound infection by p3rocedure
is shown in Table 13.
No post operative wound infections occurred in the two
months following sternal closure, cardiac trauma, pacemaker
insertion, Glenn anastomosis, Blalock-Hanlon septectomy or
other septostomy, innominate artery suspension, PA banding,
plication of diaphragm, thoracotomy, and vessel repair
procedures.
Post operative wound infections occurred in the two months
following pectus excavatum repair, central shunt, PDA
ligation, pericardial drain insertion, Blalock-Taussig
shunt and repair of coarctation of the aorta. The wound
infection onset was a mean of 12.1 days (median 13 days)
after surgery. The causative agents were Staphylococcus
aureus 70% (5/7) and coagulase negative staphylococci 30%
(2/7) .
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Table 13 Post Operative Wound Infection Following Closed
(Non CPB) Surgery
Procedure % infected (n infected)
pectus excavatum repair 100% (1)
central shunt 33% (1)
PDA ligation * 33% (1)
pericardial drain insertion 14% (1)
Blalock-Taussig shunt 7% (2)
coarctation of aorta repair 5% (1)
Post operatively, neonates who undergo ligation of an
uncomplicated PDA are routinely admitted to the
Neonatal Intensive Care Unit (NICU)
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6.3.2 Characteristics of Infections Following Open (CPB)
Surgery
Condition as measured by the PRISM score at the time of
admission to the PICU after surgery included 38% with a
PRISM score <10 and 62% with a PRISM score yl 0.
Infection at all sites
Of the patients with a PRISM score <10 10.6% (9/85)
developed infections at any site. Of the patients with a
PRISM score >/l 0 17.4% (24/1 38) developed infection at any
site (p >0.05. NS). Infections included 4 bacteraemias of
unknown primary source, 8 non-tunnelled central line
infections, 5 arterial line infections, 10 chest tube site
infections, 7 lower respiratory tract infections, 5 urinary
tract infections, 4 eye infections, 3 skin infections, 3
peritoneal drain infections / peritonitis. The 8
infections in percutaneous jugular central venous lines
occurred in lines in place a median of 8 days (range 1-10
days). The 5 arterial line infections occurred in arterial
lines in place a median of 11 days (9-20 days).
Wound Infection
No patients with a PRISM score <10 developed post operative
wound infections. Of patients with a PRISM score >,10,
10.9% (15/138) developed wound infections (p >0.05 NS) .
1 79
Post operative wound infection by operative procedure is
shown in Table 14. No post operative wound infections
occurred in the two months following Mustard Procedure,
valve (mitral/aortic) replacement, Rastelli procedure,
valvuloplasty, pulmonary arterioplasty, RVOT obstruction
repair and repair of sub aortic stenosis.
Post operative wound infections (including 3 cases of
mediastinitis), followed double outlet right ventricle
repair, truncus arterisosus repair, switch procedure,
valvotomy, cardiac conduit insertion, transverse
collaterals repair, Fontan procedure, AVSD repair, VSD
repair, ASD repair and Tetralogy of Fallot repair. Wound
infection onset time was a mean of 9.7 days (median 10
days) after surgery. The causative organisms included
singly or in combination; coagulase negative staphylococci
33% (5/15), Pseudomonas aeruginosa 27% (4/15), Candida
species 27% (4/15). Staphylococcus aureus 20% (3/15) and
each of Acinetobacter sp. enteric streptococcus and
Streptococcus viridans 7% (1 each). Mediastinitis was
caused in 3 cases by P. aeruginosa, and in one case by
Candida sp.
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Table 14 Post operative wound infection following open
(CPB) surgery
Procedure % infected (n infected)
double outlet right
ventricle 25% (1)
truncus repair 20% (1)
switch 17% (2)
valvotomy 17% (1)
conduit insertion 13% (2)
other (repair of
transverse collaterals) 13% (1)
Fontan 7% (2)
AVSD repair 6% (1)
VSD repair 6% (2)
ASD repair 4% (1)
Tetralogy of Fallot repair 4% (1)
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6.3.3. Wound Infections in Patients with Open Sternum
(Elective or Emergency)
27.6% of patients in whom the sternum was either electively
left open after surgery or re-opened as an emergency
procedure in the PICU, developed wound infection. There
was no difference in the rate of wound infection following
elective or emergency opening (5/18 vs 3/11, p >0.05 NS).
Three cases of mediastinitis occurred in 29 patients
(10.3%) where the sternum was open post operatively. In
patients where the sternum was at no time open post
operatively 4.6% (13/281) developed post operative wound
infection (p = 0.00028) see Table 15.
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Table 15 Incidence of post operative wound infection in
cardiac surgery patients with open sternum (elective or
emergency) in the post operative period
Open Sternum Other cases
elective emergency
No. of patients 18 11 281
No. wound infections 5 3 14
Wound infection ratio 27.8 27.2 5.0
(p = 0.00028, open sternum vs other cases)
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6.3.4 Summary of Nosocomial Infections
The relative frequency of nosocomial infection by site, in
cardiac surgery patients is listed in Table 16.
In proportional frequency, the incidence of bacteraemia
(including central line and arterial line infections) of
(27%) equalled wound infections (28%). The most common
isolates were coagulase negative staphylococci (30%), P.
aeruginosa (21%), S. Aureus (16%) and Candida sp. (15%).
No viral illness was identified clinically.
The relative frequency of organisms causing infection is
detailed in Table 17.
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Table 16 Relative frequency of nosocomial infection by site
in cardiac surgery patients
Site No. % of all nosocomial
infections
wound 22 28%
Bacteraemia 1°,no source 6 8%
Central Line bacteraemia
(+/- site) 9 1 1 %
Arterial Line bacteraemia
(+/- site) 6 8%
Chest tube/pacer wire site 1 1 1 5%




Peritoneal drain/peritonitis 3 4%
Gastrointestinal 0 0
Upper respiratory 1 1 %
TOTAL 78 1 00%
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Table 17 Relative frequency of organisms causing nosocomial










































This work further defines the epidemiology of infection,
following cardiac surgery, by providing procedure specific
infection rates in patients whose severity of illness is
scored using the PRISM scoring index. Open sternum and
high PRISM scores were clinically and statistically
associated with higher infection rates. The predominant
pathogens differed according to procedure. Coagulase
negative staphylococci, Pseudomonas aeruginosa and Candida
sp. were important pathogens in open (CPB) cases. (Candida
sp. has previously been reported to cause only 6% of median
sternotomy infections. (Edwards 1983)). In contrast,
staphylococci predominated in closed (non CPB) cases.
The high proportion (27%) of intravascular line related
bacteraemias and line exit site infections is noteworthy
because of the underlying heart disease which makes these
patients vulnerable to endocarditis. These infections are
generally, considered to be preventable by adherence to
strict aseptic technique during insertion and maintenance
of lines and their prompt discontinuation after a maximum
of 5 days of placement. Difficult vascular access and
unstable condition of the patient may necessitate the
prolonged use of individual lines - in this series infected
percutaneous central and arterial lines were in place a
median of 8 and 11 days respectively.
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The wound infection rate in this series is somewhat higher
than is expected from other paediatric and adult series.
(Edwards 1983) (Fisher 1981) (Archer 1983) (Dandalides
1984) (deSilva 1984) (Steffenson 1987) (Flynn 1987) (Kaiser
1984) (Simchen 1983) (Farrington 1983) (Yonkman 1984)
(Williams 1983) (Bor 1983) (Hoffman 1981) (Weinstein 1976)
(Voiriot 1987) (Kernodle 1988) (Wilson 1988) (Wray 1973).
10.7% of patients who were sicker on admission to the PICU
as measured by a PRISM score >,10 acquired infection vs 2.3%
of those with PRISM scores <10. Indeed the rate is higher
than in the period from 1 984 to 1 986 inclusive at this
hospital when overall post operative wound infection rates
for cardiac surgery patients (infections per 100
admissions) ranged from 1.1 - 1.7 for the 708 - 81 4
procedures carried out per year (unpublished data).
In the Hospital for Sick Children, Toronto, from January
1 983 till July 1 985 the total cardiac infection ratio
(including wounds) was 4.7 which is lower than neurosurgery
(13.1), general surgery (11.2), neurology (9.1), renal
(7.4), ENT (5.8) and general paediatrics (5.7) (Milliken
1988). In these earlier studies surveillance was carried
out by the Infection Control nurses using twice weekly
chart review and daily review of microbiologic reports. It
is not possible to know if the current higher rate is due
to higher intensity surveillance by the full time research
fellow in association with the use of the nursing sentinel
1 88
sheet system; sicker patients as measured by the PRISM
score; the introduction of new procedures (e.g., elective
delayed closure of the sternum); timing early in the
academic year; or other unmeasured factors.
Previous surveys have involved health record reviews over
prolonged periods of time and may underestimate infection
rates. It is believed that the intensity of surveillance
in this survey probably surpasses that of previous surveys.
While the severity of wound infection differed among
patients, there was consensus between the PICU and cardiac
surgery staff on the presence of wound infection; stitch
abscesses were not identified and cases of non
union/delayed union of the sternum without pus were deemed
insufficient for a diagnosis of wound infection to be made.
In any future study scoring of the severity of wound
infection could be undertaken as suggested by Wilson et al
(1988).
The PRISM score on return to the PICU after surgery clearly
identifies a sicker population of patients at higher risk
of infection than the uninfected group. Preventive
intervention focussing on the indications for the sternum
remaining open in the post operative period, designation of
responsibility for administration of pre and intra
operative antibiotics, duration of and monitoring of the
pre-operative skin site prep and other operating room
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procedures was co-ordinated through a series of meetings
held by the staff of Cardiac Surgery, PICU and Infection
Control during and after this study period. The early post
operative wound infection ratio in the four month period
since the end of the study and at the end of the academic
year has decreased to 2.0 using the Infection Control
Sentinel Sheet (ICSS) system of detection.
The origin of infection is not clear from this series.
Edwards (1983) reported 9 children with median sternotomy
infections (0.1%) including 3 with mediastinitis during a
12 year study period involving 6775 procedures. Risk
factors in 6 patients included one or more of: a bypass
time of greater than 1 hour, excessive post operative
bleeding, low cardiac output for 24 hours or more post
operatively, re-exploration for control of bleeding and
inadequate antimicrobial prophylaxis.
The higher PRISM scores of our infected patients and the
failure of any patients with a PRISM score <10 to develop
wound infections following open surgery is another measure
of a more difficult operative procedure in patients who
developed infection in comparison to those who did not.
While the difference in total nosocomial infection rates in
patients with PRISM scores <10 and >10 did not reach
statistical significance, either singly (by either open
(CPB) or closed (non CPB) cases), or combined, the power to
detect a difference was low. The infection rate was twice
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as high in patients with a PRISM score >,10 than those <10
(21.2 vs 9.8) and no wound infections occurred in the 85
patients undergoing open pump surgery with PRISM scores
<10. The difference in wound infection rates was
significantly different.
Others have attempted to trace cardiac infections to
contamination of hands and bedside air, exposure to soiled
utility sink aerosols (Dandalides 1984), surgery in the
face of defective air handling system, and prolonged
operative time (deSilva 1984). An outbreak of Pseudomonas
maltophilia involving 8 of 13 children undergoing open
heart surgery during a 95 week period was traced to
contamination of both the calibration device used on the
pressure monitoring system and the sensor surface of the
transducers used in this system (Fisher 1981).
Edwards (1983) has summarised reports showing an inverse
relationship between the incidence of wound infections and
the number of procedures performed yearly, noting a rate of
2% when the number of procedures exceeded 600 (Culliford
1976) (Serry 1980) (Jurkiewicz 1980) increasing to almost
6% when only 17 procedures were performed yearly (Wray
1973). Meanwhile, Culliford (1976) identified infections
in 0.4% of 227 children undergoing median sternotomy.
While as a general statement this may be true, our
experience clearly shows that high volume surgery does not
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preclude an increased incidence of infection at least in
some periods in time or the academic year.
The problem with most of the studies performed to date is
that they employ case control analysis to identify risk
factors for the development of wound infection. Correction
of the purported risk factors is associated with a decline
in infection rates. When multiple pathogens are involved
as in this report it is doubtful that a cluster of post
surgical wound infections is related to any single break in
technique (Kaiser 1984).
Prospective stratification of risk factors of patients
undergoing surgery using procedures and PRISM scoring on
PICU admission represents a preliminary attempt to overcome
this earlier problem. Further intensive prospective
analysis of risk factors during endemic and epidemic
periods could address in addition, surgical technique,
operating room protocol and environmental factors although
these may be extraordinarily difficult to quantify.
The tendency for deep mediastinal infections to be caused
by Gram negative enteric pathogens is reiterated here
(Edwards 1983) (Culliford 1976); all four cases in our
series were caused by Pseudomonas aeruginosa and Candida
sp. Similarly the onset of post operative wound infection
has previously been reported to be 10 to 15 days post
operatively (Edwards 1983) (Culliford 1976) (Serry 1980)
1 92
(Grmoljez 1975) and was in our study 13 days (median) for
closed cases and 10 days (median) for open cases.
Apart from wound and intravascular line related infections
other sites of infection are also important in these
patients. One child in the current series went to the
operating room with untreated candiduria and developed
Candida sp. wound infection post operatively. Workers in
the HSC have previously reported corneal opacity and
unilateral blindness following nosocomial P. aeruginosa
infection in a post operative cardiac patient who was
subjected to large numbers of manoeuvres about the face
(e.g., suctioning, nasogastric tube passage, endotracheal
intubation). In a study by King corneal damage was
reported in 7.4% of 30 paediatric patients with nosocomial
Pseudomonas aeruginosa conjunctivitis (King 1988).
There is a high morbidity and mortality associated with
respiratory syncitial virus (RSV) infection occurring in
children with congenital heart disease associated with
increased pulmonary blood flow. (McDonald 1982). These
patients are significantly more likely to require care in
the PICU including assisted ventilation and, are more




EVALUATION OF A NEW METHOD OF NOSOCOMIAL INFECTION
SURVEILLANCE FOR USE IN THE PICU: THE INFECTION CONTROL
SENTINEL SHEET.
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EVALUATION OF A NEW METHOD OF DETECTION OF NOSOCOMIAL
INFECTION IN THE PICU: THE INFECTION CONTROL SENTINEL
SHEET
SUMMARY
To improve the efficiency of nosocomial infection detection
in the Hospital for Sick Children, Toronto, a highly
structured system, the Infection Control Sentinel Sheet
(ICSS) has been developed. It combines initial reporting
by the bedside nurse of patient symptoms possibly related
to infection with patient follow-up by the Infection
Control Nurse (ICN).
Between 1/7/87 and 29/2/88, in the PICU, a prospective
study was undertaken which compared nosocomial infection
data obtained through ICSS with data obtained by a full
time Research Fellow (intensivist) performing daily bedside
observation/and chart review. Ratios of nosocomial
infections and nosocomially infected patients were 15.8 and
7.0 respectively among 685 admissions. (This included 5
infections identified only through the ICSS system so, in
fact, the 'gold standard' became an amalgamation of the two
systems). The sensitivities for detection of nosocomially-
infected patients by bedside review and ICSS were 100% and
87% respectively. The sensitivities for detection of
standard infections (blood, wound and urine) by bedside
review and ICSS were 88% and 85% respectively. The
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sensitivities for detection of nosocomial infections at all
(11) sites by bedside review and ICSS were 94% and 72%
respectively.
Infections missed by the ICSS were: minor (e.g., drain,
skin, eye); uncertain/needed physician diagnosis (e.g.,
otitis media, pneumonia); not requested on the ICSS (e.g.,
URI); related to follow-up of deceased patients or minor
mis-classifications / failure to associate with a device
(e.g., central line related).
Daily PICU surveillance by the ICN required only 20 minutes
per day. The ICSS appears to be a highly promising system
which has many unmeasured benefits.
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7.1 INTRODUCTION
Early and complete detection of nosocomial infection is
essential in order to initiate preventive intervention and
reduce transmission. This applies in particular to post
operative pneumonias and urinary tract infections (Haley
1985a). Surveillance methodology has recently been
reviewed by Abrutyn (1987) and is summarized in Table 2.
Currently used methods have numerous disadvantages - they
are labour intensive or insensitive, or dependent on
systems not available in all hospitals e.g., Kardex system
(Wenzel 1976a ).
At the present time, there are many new demands on
Infection Control personnel which reduce time available for
data collection. These include education about AIDS, new
procedures and products, interpretation of commensal
organisms which may be pathogens in the critically ill or
immunocompromised patient, recognition of nosocomial viral
syndromes and identification of infection in sicker
patients in association with new devices and procedures.
To provide more time for the forementioned activities, and
to heighten interest in nosocomial infection, the
responsibility for detection of infected patients (not
differentiating between community and nosocomial
infections) was shifted to the bedside night nursing staff
through an Infection Control Sentinel Sheet System (ICSS),
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an adaptation of a system initiated elsewhere (personal
communication C. Andrews, Columbus, Ohio).
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(Adapted from Freeman 1981
** by definition, all other
this standard.
(a) and Thompson 1987).
sensitivities are referable to
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The use of the ICSS hospital-wide during 1 986-1 987 was
associated with a 50% increase in the incidence of reported
nosocomial infections compared to the previous 2 years when
weekly chart review and daily lab rounds were undertaken.
See Figure 6.
To determine the sensitivity of the new surveillance
strategy, a prospective study was carried out in the
Paediatric Intensive Care Unit comparing the results of the
ICSS system with results obtained by a Research Fellow
(intensivist) independently carrying out nosocomial
infection surveillance by means of daily bedside
observation and chart review.
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Figure 6 HSC, Toronto: yearly nosocomial infection ratio
(NIR) by surveillance method.
YEARLY NOSOCOMIAL INFECTION RATIO
(NIR) BY SURVEILLANCE METHOD
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The study was performed in the setting and using the
general methods as described in Chapter 4. To detect
nosocomial infection, a Research Fellow carried out daily
bedside examination of all patients as well as in-patient
chart review as per general methodology. At the same time
the PICU continued routine use of the Infection Control
Sentinel Sheet (ICSS) under the supervision of the
Infection Control Nurse (ICN).
7.2.2 Definition of the Infection Control Sentinel Sheet
System (ICSS)
The sentinel sheet was developed and pretested on samples
of convenience; minor revisions for clarity and
acceptability were made in 1985 and the system was
introduced hospital-wide in January 1986. In The Hospital
for Sick Children, Toronto, the Admitting Department
produces the sentinel sheet at 7 p.m. and delivers it to
the PICU at 2 a.m. along with the ward census sheet. The
sentinel sheet consists of the names of each patient on the
ward with a check list of symptoms of infectious diseases
(fever, cough etc.,). A sample sentinel sheet is detailed
in Figure 7. Each bedside nurse 'flags' symptoms present
in his/her patient.
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Figure 7 Contents of the Infection Control Sentinel Sheet
(ICSS)
THE HOSPITAL FOR SICK CHILDREN
INFECTION CONTROL





PATIENT NAME TEMP INCISION SEPTIC IV/SITE URINE DIARRHEA ISOLATE CENT LINE/ CHESTTUBE


































Differentiation between community and nosocomial infections
is not required on the ICSS system. The completed ICSS is
signed by the Charge Nurse at the end of his/her shift and
is placed in a box in the PICU; sheets are collected daily
at approximately the same time in the morning from Monday
to Friday by the ICN. On Monday, sheets for the previous
Friday through to the Sunday are collected. During absence
for sickness/holidays the sentinel sheets are saved and
given to the ICN on her return. The remainder of the
process constitutes the ICSS.
Patients, identified on the sheet as having symptoms or
signs of infection, are discussed by the ICN with the
charge nurse or responsible nurse. Flow sheets and medical
records are reviewed by the ICN and if a nosocomial
infection is confirmed, a detailed surveillance report is
completed for computer entry to the nosocomial infection
data base. In addition to the sentinel sheet, the system
includes correlation of specific microbiology results by
the ICN. All positive blood, CSF, peritoneal fluid and
joint aspirate cultures as well as multiple resistant
organisms are recorded on a computer print out sheet in the
laboratory and are available to the ICN each morning.
Wound, eye and skin culture reports are compiled manually
for daily pick up. Enteric and respiratory viral specimen
results are reviewed twice daily. Clostridium difficile
toxin and hepatitis B serology are reviewed daily. A
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monthly print-out of all positive viral specimens is
provided for the ICN by the Virology department.
If a nosocomial infection is confirmed, a surveillance
report is completed by the ICN. Surveillance reports are
verified weekly by the Infection Control Physician and a
computerized report is returned to the PICU Nursing Unit
Administrator and the PICU Director the following month.
The sentinel sheet had been in use in the PICU for the 18
months prior to the study. The sentinel sheet is
introduced to and reviewed with new staff by clinical
instructors and the ICN at their respective ward nursing
orientations.
7.2.3 Data Entry
ICSS data from the routine surveillance were entered and
analyzed on Apple lie using an Infostar System(R) (micropro
International Cord) data base programme. Data from the
bedside observation and chart view exam were managed by the
Research Fellow independently of the ICSS and Infection




Infections were reported as Nosocomial Infected Patient
Ratio (NIPR) and as Nosocomial Infection Ratio (NIR).
NIPR = no. of infected patients
no. of admissions x 100
NIR = no. of infections
no. of admissions x 100
The 'gold standard' was determined by amalgamating the
number of infections identified by bedside
observation/chart review (BSO/CR) and the ICSS. Results
obtained from each system were compared to determine
sensitivity. No attempt was made to exclude infections
identified by either system from the pool of infections
forming the 'gold standard'. Specificity could not be
calculated reliably because patient identification in the
ICSS included community acquired infections.
7.3 RESULTS
7.3.1 Prevalence of nosocomial infection
685 patients were admitted during the 8 month study period;
108 infections were identified in 48 patients (NIPR = 7.0,
NIR = 15.8). This total includes 7 infections identified
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through the ICSS but not identified through bedside
observation (secondary bacteraemia, skin infection, urinary
tract infection (3 cases), infected chest drain site and
superficial post operative wound infection).
7.3.2 Sensitivity in detection of infected patients
BSO/CR identified all infected patients. The ICSS detected
40 of 46 (87%) of infected patients. This included 15/20
(75%) of patients with single infections and 25/26 (96%) of
patients with 2 or more sites of infection (see Table 18).
Among those patients with a single infection who were not
detected by the ICSS, the infections included pneumonias
(2), conjunctivitis (2), and otitis media (1). The only
patient with multiple infections who was not identified by
the ICSS had a mixed bacteraemia with Micromuciliginosis
sp, in a peripheral blood culture and alpha haemolytic
streptococci in a central line blood culture.
207
Table 18 Comparative sensitivity in the detection of
infected patients: Infection Control Sentinel Sheet v bed¬
side observation.
Patients Sensitivity of system
ICSS* BSO / CR**
all infected patients 0.87 1.00
patients with 1 infection 0.75 1.00
patients with >2 infections 0.96 1.00
ICSS = Infection Control Sentinel Sheet System
BSO/CR = bedside observation / chart review
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The ICSS identified 80% or more of infections at the
following sites (see Table 19): arterial line (100%), GI
(100%), wound (93%), CVL (86%), bacteraemia (83%).
Respiratory and superficial/minor (drain, eye, skin)
infections were inconsistently identified. BSO/CR included
daily chest X-ray review while the ICSS did not. Upper
respiratory infections were not listed on the ICSS because
of the difficulty in interpreting symptoms in the intubated
patient; those infections missed were physician diagnosed
(1 case of herpes glossitis, 3 cases of otitis media).
There were problems verifying infections (14 cases) in
patients identified on the ICSS. Reasons included the
following:-
1) chart unavailable (1 patient with 1 each of
bacteraemia, central line infection, arterial line
infection, wound infection and urinary tract
infection).
2) misclassification
arterial line infection (2) misclassified as blood
wound (1) misclassified as skin
drain (1) misclassified as wound.
3) dismissal of pathogen as a contaminent in: central
line (1); arterial line (1); urine (1).
4) failure to recognize multiple episodes of infection
occurring within a short period of time (central line
infection at each of jugular/arm sites within a 72
hour period (2 cases).
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Table 19 Comparative Sensitivity by method and site of
infection: Infection Control Sentinel Sheet v bed-side
observation.
Site (no. detected by Sensitivity Sensitivity
gold standardP of BSO/CR2 of ICSS3
(no. ) (no. )
bacteraemia (12) 92% (11 ) 83% (10)
CVL (14) 1 00% (14) 86% (12)
arterial line (12) 1 00% (12) 1 00% (12)
wound (14) 93% (13) 93% (13)
resp. upper (7) 1 00% (7) 43% (3)
resp. lower (12) 1 00% (12) 42% (5)
urine (14) 79% (11 ) 79% (11 )
GI (1 ) 1 00% (1 ) 1 00% (1 )
eye (5) 1 00% (5) 40% (2)
drain (14) 93% (14) 64% (9)
skin (3) 67% (2) 33% (1 )
TOTAL (108) 94% (102) 73% (79)
gold standard - amalgamation of all infections
identified by daily bedside observation and the
Infection Control Sentinel Sheet system
bedside observation / chart review by Research Fellow
Infection Control Sentinel Sheet System (ICSS)
flagging by bedside nurse on night shift.
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7.3.4 Measured benefits of Infection Control Sentinel
Sheet over bedside examination.
Additional infections and additional microbes were
identified. As noted above, seven additional infections
were identified through the ICSS, but not through the
BSO/CR. Five additional organisms reported by the ICSS
system include two S. aureus (wound related), 2 coagulase
negative staphylococci (wound, chest drain related), and 1
pseudobacteraemia (Pseudomonas putida (Simor 1985) ), as
well as the isolates associated with the forementioned 7
sites, a total of 13 organisms.
7.3.5 Unmeasured benefits of Infection Control Sentinel
Sheet
The time spent in the PICU each day for: collection of the
ICSS, review of flagged patients and completion of a data
entry sheet is 20 minutes. Additional unmeasured time is
spent on daily lab rounds and occasionally in the Health
Records Department reviewing charts of patients who were
unavailable on the ward but flagged on the ICSS.
The ICSS facilitates correlation with findings on
microbiology laboratory surveillance.
The system involves bedside nurses and charge nurses who
know the patient best; it may heighten their awareness of
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infection and their interest in its prevention. It reduces
time spent on surveillance by the ICN and makes more time
available for the other functions of the ICN, especially
teaching. It facilitates regular ward interaction,
heightens awareness of nosocomial infections and provides
an opportunity to review isolation of patients with both
community acquired and nosocomial infections.
7.3.6 Biases
Biases acting to underestimate the sensitivity of the ICSS
include the broad spectrum of infectious events and
attribution of infections to devices. Additional care must
be taken to identify the sampling site and line to provide
this latter service. Also diagnoses not clearly listed on
the sentinel sheet were included in the gold standard e.g.,
otitis media, URTI. Comparison to sustained, period
prevalence surveys more commonly used to determine
sensitivity.
The time dedicated by the intensivist (3 hours per day) to
this study makes BSO/CR underreporting and overestimation
of the ICSS unlikely. While the Hawthorne effect could be
improving use of the ICSS, the system had been in place for
18 months prior to study and the research fellow had been
working as a clinical fellow in the PICU the previous year




The ICSS provides a method which is complete, concurrent,
efficient and simple. It provides the opportunity for
close interaction with nursing staff and shifts ICN
responsibility from case finding to case verification.
Surveillance activities have been defined as active, if
Infection Control personnel perform case-finding, and
passive, if dependent on reporting care givers. There are
several unique features of this active system which
differentiate it from a passive system. Unique
characteristics include:
1) daily computerized list of ward patients and symptoms
of infection
2) nightly delivery of ICSS to ward by Admitting
Department staff
3) night nurse 'flags' symptoms present in her patients;
differentiation between community and nosocomial
infections is not required
4) night nurse and charge nurse 'sign off' the ICSS
5) scheduled daily 'pick-up' of ICSS in the morning by
the ICN
6) review of 'flagged' patients by ICN
The implementation of this system hospital wide, in 1986,
resulted in approximately a 50% increase in reported
nosocomial infection in the two year period during which
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concurrent chart review on each ward (PICU, NICU twice
weekly; others weekly) by the ICN was combined with daily
laboratory result review. See Figure 9.
The ICSS is highly sensitive identifying 87% of infected
patients, 75% of patients with a single infection and 96%
of patients with two or more infections. The sensitivity
testing undertaken here was particularly rigorous. The
'gold standard' included daily surveillance by a trained
intensivist for the eight month period rather than point
prevalence surveys by physicians; infections at 11 sites
rather than only the four major sites (blood, urine, wound,
lower respiratory) were sought, and attribution of
infection to particular indwelling devices was attempted.
Sensitivity can be improved relatively easily, if staff
agree on what they want reported. For example; diagnoses
of bacteraemia can be clarified to include all pathogens,
greater care can be taken in specimen collection in
suspected IV related infection and ICN review of blood
cultures and chest x-ray review of films with the unit
radiologist can be added. In general, problems relate to
interpretation of purported pathogens, completeness of
culturing, limitations of clinical diagnosis and
availability of charts/patients for review, all of which
must be dealt with in a limited period of time. Collection
of blood specimens through lines by bedside nurses with
omission of peripheral blood cultures, in patients with
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difficult access requiring sampling by a physician, makes
the diagnosis of line-related infection difficult.
Respiratory infections were the only site of major
importance not detected by this system. The poor
sensitivity in detecting lower respiratory infections could
be improved through systematic review of x-rays, although
the difficulty in diagnosing pneumonia in the ventilated
patient is well known. It is possible that the occurrence
of these infections was over-reported by the dedicated
intensivist. Other diagnoses such as otitis media and
sinusitis are particularly dependent on the assiduousness
of case finding and application of diagnostic tests.
It is of interest that the so called 'gold standard' of bed
side review was not 100% sensitive in detecting infections
at all sites at least over a prolonged period of time (8
months).
Surveillance needs in the 1980's have evolved substantially
with the recognition of serious viral infections,
particularly in paediatric patients and with a sicker
paediatric patient population subjected to numerous
invasive procedures. Comprehensive surveillance including
all sites and associations with indwelling devices is
required to identify problems in a PICU and at present no
efficient surveillance system exists which adequately
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fulfils these criteria in the limited time available to
Infection Control personnel.
These data were collected in twenty minutes per day on the
ward (and routine laboratory rounds) from trained bedside
nurses in a unit which had been using the system for 18
months. The unique setting in which this study was
undertaken should be appreciated. The PICU had a well
developed Infection Control programme including previous
research; the ICN was well known to the staff as was the
ICSS; a strick schedule of delivery, completion and pick¬
up of the ICSS was adhered to.
Finally, underreporting is an important problem in any
passive surveillance system, although it varies with the
illness involved. Passive systems depend on non-Infection
Control personnel who: understand definitions, apply
definitions consistently, are aware of the need to report
infection, and are willing to do so. Infection Control
personnel then perform a verification function (Abrutyn
1987). According to Hoffher (1979), specific problems
previously associated with an insensitive physician based
ward reporting system, which it is believed have been
addressed here, include: primitive and fragmentary
classification of infections; definitions not
standardised; time consuming completion of another chart
sheet; retrospective case finding; self incriminating;
information not co-ordinated by one person.
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This detection system appears very promising and worthy of
further study. It creates an environment conducive to the
exchange of information about infection control while
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ADVERSE SEQUELAE OF NOSOCOMIAL INFECTION IN THE PICU
SUMMARY
The incidence of certain events, judged by PICU personnel
to be of adverse clinical significance, and which occurred
as a direct consequence of nosocomial infection, was
reported prospectively in the PICU population over a period
of 8 months. During the study period 685 patients were
admitted; 48 patients developed one or more nosocomial
infections. Antibiotic treatment was indicated in 36
infected patients (75%); other adverse events (removal of
a therapeutic device; cancellation or delay of surgery;
extra surgery; isolation; readmission to PICU) occurred
in 20 patients. A crude costing study of antibiotic
required for treatment of nosocomial infection suggested
that the minimum drug cost for 100 nosocomial infections
was Can$ 15,000 (approximately £7,500). Mortality rates in




Traditional associations of nosocomial infection with
sequelae such as increased mortality, increased morbidity
and increased length of stay/patient care expenditure are
limited since results are affected by the confounding
effects of multiple uncontrolled variables.
With regard to mortality; care must be taken when
attributing death to nosocomial infection since multiple
factors such as birth weight and underlying illness make
substantial contributions to mortality in the same
population. (Goldmann 1983). In adult ICU patients, using
the technique of step-wise logistic regression analysis, a
positive association between nosocomial infection and
mortality has been demonstrated (Craven 1988). This
technique, however, has not been applied in studies of
paediatric ICU patients, and in this group, it remains
unclear whether mortality in nosocomially infected patients
reflects causality or merely identifies a more severely ill
group of individuals. (Brown 1987).
There have been efforts to derive increased patient care
expenditure in adult patients, by estimating prolongation
of hospital (or ICU) stay as a result of nosocomial
infection. (Craig 1984) (Freeman 1979). Prolongation of
stay is assessed by means of a matched cohort study or else
by using the subjective estimates of physicians. There are
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associated difficulties: adequate numbers of matched
controls may be hard to find; both matched studies and
subjective estimates are subject to the confounding effects
of multiple uncontrolled variables. Estimates vary
depending on whether the study is incidence or prevalence
in type.
Problems abound when one attempts to associate nosocomial
infection and morbidity not least of all because of a lack
of meaningful, descriptive terminology with which to
describe morbidity. Terms, traditionally used in
paediatric patients, e.g., ' loss of school days', 'days
not up to the play room', etc., are not relevant in the
acute environment of the PICU. In critically ill patients
there is a complex interaction between biological disease
of individual body systems and the patient as a whole.
Hence it may be impossible to distinguish accurately,
between the biological sequelae of nosocomial infection and
biological features of the underlying disease. The issue
is further complicated by the fact that critically ill
children exhibit an extremely wide range of pathology and
age related response to illness.
To date, there has been no formal assessment of the
adverse sequelae of nosocomial infection in the PICU though
the literature does contain isolated reports both of
fatalities and of increased expenditure attributable to
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specific nosocomial infections in paediatric patients.
(McDonald 1982) (Mufson 1973) (Pinner 1982).
Since associations of nosocomial infection and commonly
accepted outcomes have so many limitations, an alternative
approach has been sought. This is to select a number of
specific events which are judged, from a clinical
standpoint, to be of adverse significance, and then observe
the incidence of these events as a direct consequence of a
nosocomial infection.
The aims of this study were:-
1 ) to observe the incidence of certain clinical events
(unscheduled surgery, cancellation or delay of
surgery, removal of a therapeutic device, days of
isolation, re-admission to the PICU, antibiotic use)
as a consequence of nosocomial infection.
2) to undertake a crude costing study of antibiotic
required for the treatment of nosocomial infection.





The study was performed in the setting and using the common
methods as described in Chapter 4.
8.2.2 Adverse Clinical Events
Following discussion with PICU physicians and nursing
staff, certain clinical events were selected, each of which
was considered to be an adverse effect of a nosocomial
infection. The event had to occur solely because of
nosocomial infection; if there was doubt in respect of
this, then the occurrence of the event was disregarded.
The incidence of events was documented for each infected
patient and entered on Data III collection sheet (Figure
8). The following events were chosen for use in the
study:-
1) any type of isolation (complete room isolation; skin
or wound precautions) required specifically because of
nosocomial infection.
2) cancellation of surgery - any episode where
anticipated surgery was cancelled or delayed
specifically because of nosocomial infection.
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3) removal of a therapeutic device specifically because
of nosocomial infection. This did not apply to
devices which were removed for some other reason
(e.g., not functional, not required) and thereafter
found to be infected.
4) extra surgery - the occurrence of surgery, which was
not anticipated and, which was required directly
because of nosocomial infection. Examples include:-
debridement and resuturing of a sternal wound because
of nosocomial infection; surgical insertion of a
central venous line for administration of antibiotic
required for the treatment of nosocomial infection.
5) readmission to the PICU because of nosocomial
infection. It is recognized that this particular
assessment may be open to confounding. In some
instances the situation is entirely clear - for
example a nosocomially infected median sternotomy
wound which requires further debridement and
resuturing and hence PICU admission post operatively.
If it was not entirely clear whether or not PICU
readmission was a direct consequence of nosocomial
infection, a consensus decision by the patient's
attending physician and the PICU physician was made.
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6) days of antibiotic treatment for nosocomial infection.
This referred to:-
a) therapy instituted for and continued for
nosocomial infection.
b) therapy instituted for some other reason and then
continued (because of the development of
nosocomial infection) when it would otherwise
have been discontinued.
The Drug Information Service in the Hospital for Sick
Children, Toronto, provided an estimate of unit dose cost
for each based on a 5kg. patient with normal renal and
hepatic function. This included drug acquisition cost per
dose plus the estimated pharmacy cost per dose. The
individual weights of infected patients were used to
calculate the total cost of each drug.
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Results are presented in three sections
the incidence of adverse clinical events; mortality rates
in infected and uninfected patients, and the antibiotic
costing study.
8.3.1 Incidence of adverse clinical events
A total of 48 patients developed 100 nosocomial infections
while in the PICU and as a result 20 adverse events
(excluding antibiotic use) occurred. These were: 8
instances of a requirement for extra surgery; 7 instances
of removal of a therapeutic device; 1 instance of delayed
surgery; 1 instance of isolation; 3 instances of
readmission to the PICU. Thirty six infected patients
received antibiotic treatment for their nosocomial
infections. Table 20 details the incidence of adverse
clinical events in association with infected patients.
227






cardiac conduit re-do (2)
sternum re-suturing (3)
re-insertion PD cath. (1)

















TOTAL NO. ADVERSE EVENTS = 20
TOTAL NO. INFECTED PATIENTS = 48
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8.3.2 Mortality
The overall mortality rate in the PICU was 10% (69/685)
with deaths in 1 0% of patients without nosocomial infection
(63/637) and deaths in 12.5% of patients with nosocomial
infection (6/48) (p >0.5).
8.3.3 Antibiotic Costing Study
The cost of individual antibiotic drugs is detailed in
Table 21. Cost is based on unit dose preparation (except
in the case of ampicillin and clindamycin) in a 5 Kg.
patient with normal renal and hepatic function. The total
cost of each antibiotic is detailed in Table 22.
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amphotericin 1mg/kg=5mg $2.88 $3.20
ampicillin 25mg/kg=125mg $0.80 NA**
cefotaxime 50mg/kg=250mg $3.17 $3.58
ceftazidine 50mg/kg=250mg $3.88 $4.29
cefuroxime 25mg/kg=125mg $0.99 $1 .26
clindamycin 10mg/kg=50mg $0.46 NA**
cloxacillin 50mg/kg=250mg $0.47 $0.65
gentamicin 2.5mg/kg=12.5mg $0.31 $1 .99
metronidazole 1 0mg/kg=50mg $0.57 $0.80
piperacillin 75mg/kg=375mg $1 .24 $1 .54
ticarcillin 75mg/kg=375mg $1.12 $1 .54
tobramycin 2.5mg/kg=12.5mg $0.73 $2.41
vancomycin 10mg/kg=50mg $2.16 $2.49
based on a 5kg. patient with normal renal and hepatic
function.
based on unit dose preparation. Costs would be higher
with non-unit dose distribution.
ampicillin and clindamycin are reconstituted and the
doses are prepared on each nursing unit by nursing
staff, not by pharmacy.
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Table 22 Total cost of intravenous antibiotic for treatment
of nosocomial infection*
Drug cost/dose no. days total
treatment cost
amphotericin $3.20 91 $420.00
ampicillin NA 32 $160.00
cefotaxime $14.32 23 $2148.00
ceftazidine $17.16 45 $9116.00
cefuroxime $3.78 22 $165.00
clindamycin NA 20 $246.00
cloxacillin $2.60 88 $460.00
gentamicin $5.97 96 $1344.00
metronidazole $0.80 8 $12.00
piperacillin $6.16 28 $188.00
ticarcilliii $6.16 5 $22.00
tobramycin $7.23 1 2 $596.00
vancomycin $9.96 44 $450.00
TOTAL COST Can$15,327.00
based on estimated pharmacy cost per dose
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8.4 DISCUSSION
In this study in a Paediatric Intensive Care Unit, the
adverse sequelae of nosocomial infection have been
expressed in simple terms which, it is hoped, are
meaningful to the practising clinician. The clinical
events, whose incidence is reported in this study, were
selected after consultation with PICU physicians and
nursing staff who judged them to be of adverse clinical
significance.
This approach has certain limitations which must be clearly
understood. Firstly, data must be gathered prospectively
since a knowledge and understanding of the exact clinical
circumstances surrounding individual episodes of infection
is mandatory before any adverse sequelae can reliably be
attributed to that infection. Secondly, only a very
conservative estimate of antibiotic expenditure is
provided; the costing study counted only intravenous
antibiotic prescribed for proven nosocomial infections. It
did not include oral antibiotic (cost relatively trivial)
or antibiotic prescribed empirically for 'presumed sepsis'
which was discontinued after the results of a 'septic
workup' showed negative.
Broadly speaking, infections produce adverse effects which
can be arbitrarily separated into one of three: general
discomfort, anxiety or inconvenience to patients, parents
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or staff; specific detriment to the patient (or risk
thereof); and increased patient care expenditure.
General discomfort, anxiety or inconvenience to patients,
parents and or staff are self explanatory. For example,
anticipation of extra surgery or delay in surgery caused
additional stress to parents and patients, the re-siting of
indwelling vascular catheters (removed because of
infection) often required additional sedation or even
paralysis of the child. Technical procedures themselves
were, at times, remarkably time consuming for the attending
staff. Equally obvious, is increased cost resulting from
nosocomial infection. Surgical procedures requiring
sterile operating room facilities and/or cardio-pulmonary
bypass, disposable items used for isolation techniques,
costly devices e.g., double lumen CVL all contribute to
overall increased patient care expenditure.
Nosocomial infections cause effects, whose implications,
frequently can only be assessed when the clinical
circumstances are taken into consideration. For example,
delay in surgery, as occurred in one patient in this study,
may be extremely detrimental if there is a recognized
optimum timing for a procedure and this is missed. The
case in question involved a neonate with coarctation of the
aorta plus transposition of the great vessels with intact
ventricular septum. This infant developed a nosocomial
wound infection following emergency repair of his
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coarctation when a few hours old. As a result the
definitive surgical procedure (arterial Switch procedure
(Jatene 1976)), was delayed. There is a need for caution
in advising arterial switch repair for TGA with intact
ventricular septum in patients who are more than 2 weeks
old. In such patients the posterior ventricle rapidly
diminishes in mass shortly after birth (Lev 1969) (Tynan
1972), and becomes incapable of sustaining the systemic
circulation after anatomical correction (Yacoub 1976)
(British Medical Journal 1976). In our case, surgery was
delayed only 10 days and fortunately arterial switch was
not precluded. To our knowledge this infant suffered no
deleterious effects but this was, potentially, an extremely
serious sequel to a nosocomial infection.
Isolation techniques range from total isolation (separate
room, gown and glove for patient contact) to skin or wound
isolation only (gown and glove for patient contact). Our
single case (an infant) required 14 days of skin/wound
precautions for pseudomonas aeruginosa infection. Effects
of this included: an absolute requirement for a 1:1
nurse:patient ratio at all times; complicated patient
transfer outwith the PICU for procedures e.g., CT scan in
radiology department and reduced physical contact with
patients. In a recent randomized comparative trial in a
PICU, Klein (1987) studied the use of gown and gloves for
all patient contacts and claimed that reduced handling of
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the child (e.g., patting, soothing gestures) did not occur
but this was not our subjective experience.
With regard to extra surgery; apart from the inherent risk
of individual procedures themselves, without exception,
there was a requirement for general anaesthesia in an
already compromised child. Eight patients required extra
surgery; 5 were cardiac surgical patients with infected
post operative wounds including 2 patients with deep
mediastinitis. In 3 cases debridement and resuturing of
sternotomy wound was required; in another 2 cases a total
revision of an infected intra-cardiac conduit system,
requiring cardiopulomonary bypass, was necessary.
Removal of a therapeutic device because of infection was
indicated in 7 patients; in 3 patients a central venous
line was removed and in 2 of these there was necessity for
a new line to be inserted (in one case as a surgical
procedure, under general anaesthesia).
Readmission to the PICU was indicated in 3 patients all of
whom had acquired infection of cardiac post operative
wounds during their first PICU admission. These patients
required debridement and resuturing of the sternotomy wound
with routine admission thereafter. In all three patients
the original surgery was deemed to have been successful and
unlikely to require revision, therefore, readmission (as
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well as extra surgery) was due solely to nosocomial
infection.
This study has demonstrated that in 48 patients who
developed nosocomial infection, intravenous antibiotic
costs alone were at least Can$ 15,500 (approximately
£7,500). The incidence study reported in Chapter 5 reports
of nosocomial infection rate of 7 infected patients per 1 00
patients admitted; 15 infections per 1200 patients
admitted / 15 infections per 100 patients admitted. The
PICU has an annual admission rate of 1,400 patients,
therefore, in one year the projected cost of antibiotic for
treatment of nosocomial infection would be at least
Can$30,000 (£15,000). Clearly, this sum is an extremely
conservative estimate. It does not include the cost of
antibiotic administered because of suspicion of nosocomial
infection - this was usually continued until cultures taken
as part of a septic work-up were reported negative.
Calculations did not take account of associated costs of
drug administration e.g., IV infusion equipment, plasma
drug assays for therapeutic monitoring etc.
In the incidence study described in Chapter 5, it was
reported that the most frequent organisms causing
nosocomial infection in this PICU were staphylococci (CONS)
(30% of cases); Staphylococcus Aureus (8% of cases),
Pseudomonas aeruginosa (21% of cases) and Candida species
(19% of cases). Accordingly, in this PICU the use of
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potentially hazardous antibiotics, notably gentamicin,
vancomycin and amphotericin, is often indicated. During
the study period, for treatment of nosocomial infection, 6
patients received a total of 96 days treatment with
gentamicin; 4 patients received a total of 44 days
treatment with vancomycin; 5 patients received a total of
90 days treatment with amphotericin; 2 patients received
vancomycin and amphotericin simultaneously and 1 patient
received vancomycin and gentamicin simultaneously.
Nephrotoxicity has been associated with the use of
vancomycin since its introduction (Waisbren 1960). Farber
et al ( 1 983) in a retrospective study of the toxicity of
vancomycin preparations reported incidences of nephrotoxity
of 5% when vancomycin was used alone, 10-26% when
aminoglycoside was used alone and 35% when vancomycin was
used in combination with an aminoglycoside. Odio (1984)
has suggested that this phenomenon, known as 'synergistic
toxicity', may be a problem in children though Swinney et
al (1987) have disputed this fact.
Koren (1988) recently studied the pharmacokinetics and
adverse effects of amphotericin B in infants and children.
In his series 4 children developed serious effects
(generalized pain requiring narcotic; flushing, chills and
fever requiring diphenhydramine; urticaria; nausea and
vomiting). Furthermore 11 patients out of 13 developed a
significant reduction in serum potassium despite daily
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supplementation; 6 out of 7 developed a significant
increase in plasma urea and 6 out of 9 developed a
significant increase in plasma creatinine. Recurrent
hypokalaemia was certainly noted in many of our patients
who were receiving amphotericin though this was not
formally studied.
It is recommended that because of the large pharmacokinetic
variability and the high rate of serious adverse effects,
individualized dosing of amphotericin B based on
therapeutic drug monitoring should be performed (Koren
1988). Likewise drug monitoring is mandatory when using
gentamicin and vancomycin. Drug assays such as these
performed perhaps every other day, certainly add to the
overall cost of the antibiotic treatment, though this study
did not seek to quantify this aspect.
Vancomycin and amphotericin have other significant
disadvantages; intravenous administration of these drugs
is irritant to veins (and may ultimately require use of a
central venous line); both drugs require dilution in a
relatively large volume of fluid which, in the small child,
may constitute almost the entire fluid allowance for 24
hours, and preclude administration of other 'useful' fluids
e.g., parenteral nutrition.
As discussed previously, prolongation of stay and increased
cost secondary to nosocomial infection may be estimated by
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means of a matched cohort study (see Section 1.5.4) though
studies in adult patients have been beset by difficulties
finding adequate numbers of matched 'control' patients. It
may be assumed that in the PICU, because of the wide range
of pathology and age related response to illness, the tasks
would be even more onerous and for this reason, it was
decided not to attempt a formal matched cohort study nor to
attempt subjective, physician-based estimation of
prolongation of PICU stay.
With regard to mortality; the relationship between
mortality; severity of underlying illness and development
of nosocomial infection is discussed in Chapter 5 of this
volume. In this survey, mortality rates in infected and
uninfected patients did not vary significantly and it is
suggested that nosocomial infection rate does not increase
mortality though the power to detect a difference is low.
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CHAPTER 9
SUMMARY AND GENERAL CONCLUSIONS
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SUMMARY AND GENERAL CONCLUSIONS
The following summarises the principal findings and
conclusions drawn from results of the studies described in
the previous section.
The Present
This survey reports an overall nosocomial infection rate of
7 infected patients per 100 admissions (or 14.6 infections
per 100 admissions), over a period of eight months, and in
a population characterized by underlying severity of
illness, in the PICU, Hospital for Sick Children, Toronto.
The commonest infecting organisms are coagulase negative
staphylococci, Pseudomonas aeruginosa, Candida species and
Staphylococcus aureus. The commonest sites of infection
are blood stream, skin/eye/wound; respiratory tract and
urinary tract.
With regard to cardiac surgery patients; the common
causative agents in wound infections following closed (non
bypass) cases are Staphylococcus aureus and coagulase
negative staphylococci. Following open (bypass) cases
wound infections are caused most frequently by coagulase
negative staphylococci, Pseudomonas aeruginosa, Candida
species and Staphylococcus aureus. Overall, non-wound
infections account for 72% of total infections.
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In this PICU, nosocomial infection creates a significant
burden of illness - physical, emotional and financial,
which is ultimately borne by the patients, by their
families and by the institution. The study confirms that
certain events (considered to be of adverse clinical
significance either because of anxiety/discomfort/
inconvenience to patients/parents/staff or because of
increased cost) occur in up to 40% of infected patients.
Nosocomially infected patients invariably require
antibiotic treatment. The minimum drug cost for 100
nosocomially acquired infections is $15,000. Mortality
rates do not appear to be significantly increased as a
result of nosocomial infection.
There is no doubt that the era of unlimited medical
resources has ended. In the United States, for example,
the cost of health care has increased more rapidly than the
rate of inflation (Freeland 1980). Patients in critical
care units consume a disproportionate quantity of hospital
resources, especially paradoxically, those patients with
the poorest prognosis for survival (Cullen 1984) (Schroeder
1981) (Detsky 1981) (Scheffler 1982).
As discussed in the introduction to this thesis, if the
burden of illness created by nosocomial infection in
paediatric intensive care units is to be reduced, two
crucially important issues must be addressed namely;
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predisposing risk factors and efficient infection
surveillance strategies.
Risk factors for the acquisition of infection have to be
identified in order to guide allocation of resources in
infection control and focus future research efforts. In
study populations, predisposing risks have to be clearly
understood before the efficacy of any particular
intervention strategy can be assessed. Interventions
themselves may be expensive and to be cost-effective may
need to be applied selectively to targeted cases,
considered to be at risk of infection.
Efficient infection surveillance strategies must be devised
in order to identify infection accurately and rapidly
thereby reducing the use of unnecessary antibiotic therapy
yet averting the progression to life threatening sepsis.
To be practicable, surveillance strategies must be suitable
for day to day use in a busy PICU where there are,
inevitably, limitations on available Infection Control
Staff time.
This study demonstrates that severity of underlying
illness, as measured by the PRISM scoring system, predicts
a population in the PICU who are at risk of developing
nosocomial infection. Patients with an admission PRISM
score of yi 0 are significantly more likely to acquire
infection than those with scores <10 (10.8% vs 3.6%,
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p<0.001). In cardiac surgery patients additional risk
factors for acquisition of infection may be identified.
These relate to certain surgical procedures and specific
surgical techniques namely an 'open' sternum in the
immediate post operative period. It is particularly
advantageous that using these markers patients may be
stratified by risk from the moment of admission hence
intervention strategies applied from the outset of their
stay.
With regard to an effective nosocomial infection
surveillance strategy; the sensitivity of the system of
surveillance recently introduced for routine use in the
PICU, (the Infection Control Sentinel Sheet (ICSS) ), has
been found to compare very favourably with daily bedside
examination of patients plus chart review. The ICSS system
requires only 20 minutes of surveillance time per day and
detects: 87% of nosocomially infected patients; 85% of
infections at the three standard sites (blood, wound and
urine); and 72% of infections at all 11 sites surveyed.
Following this study, it is intended to make some minor
adjustments to the system to improve its sensitivity.
The Future
During the last decade researchers in adult critical care
units have identified a variety of infection control
techniques and future research efforts have been focussed.
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These techniques can be variably applied to the situation
in the PICU since the distribution of infection within
these two units differs. In the light of the findings of
this study, some of the current innovations in nosocomial
infection control in critical care units will be reviewed
and areas where future research should be directed will be
identified.
As a general statement, there is a requirement to devise
and evaluate strategies which block transmission of
organisms between patients and which prevent, or at least
delay, nosocomial colonization. The use of simple barrier
precautions warrants further study. Some workers have
demonstrated the use of protective isolation to be useless
(Donowitz 1986a) (Preston 1980) though Leclaire et al
(1987) recently showed that routine use of gown and gloves
in a paediatric unit significantly reduced the incidence of
endemic respii'atory syncitial virus infection Klein (1 987)
found in a 2 1/2 year prospective randomized comparative
trial in a PICU that the use of disposable, nonwoven
polypropylene gowns and latex gloves for all patient
contacts reduced the incidence of nosocomial infections two
fold.
In this PICU, skin/eye/drain site infections account for
22% of the total and wound infections for 15% of the total.
More studies of cutaneous antiseptics (used for hand
washing, intravascular line site care and patient bathing)
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are needed with infection rather than colonization as the
index of comparison.
Vascular line related infections account for 24% of the
total infections and catheter associated urinary tract
infections for 9% of the total. There is considerable
evidence that the material used in construction of a device
for implantation is an important determinant in whether
there is an attractive surface for adherence of pathogenic
micro-organisms. (Ashkenazi 1984) (Gristina 1987).
Current research efforts are being directed towards new
designs which reduce colonization of surface polymers and
the development of non thrombogenic, colonization resistant
polymers possibly incorporating antimicrobials onto
surfaces or onto the polyer itself. (Trooskin 1985)
(Schaeffer 1988) (Maki 1987). The addition of non toxic
biodegradable antiseptics to intravenous fluids is another
possibility. (Freeman 1982).
This study reports that lower respiratory tract infections
account for 10% of total infections. In adult ICU
patients, where the incidence of nosocomial pneumonia is
considerably greater, there is little evidence that
significant progress is being made in either its prevention
or its treatment. More information is needed on the
effects of gastric colonization, the frequency of gastric
reflux and the role of the nasogastric tube as a risk
factor.
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It is suggested that oral and gastrointestinal tract de¬
contamination with topical, non-absorbable antibiotics
prevents nosocomial respiratory infection in ICU patients
(Stoutenbeek 1987) (Unertl 1987) (Ledingham 1988) though
epidemiologically, the long term results of such a policy
are unclear. Driks et al (1987) recently have demonstrated
that the use of a 1 cryoprotective1 gastric barrier agent
(sucralfate) which preserves the natural gastric barriers
against bacterial overgrowth), rather than antacids or H2
antagonists for stress prophylaxis, reduced the incidence
of nosocomial pneumonia two fold. In vitro data presented
by Daschner (1988) and Tryba et al (1987) suggests that
sucralfate may also have an intrinsic antibacterial effect
against gram negative bacilli that is greater than that
observed with gastric acid. At the present time, neither
of these techniques has been assessed in paediatric
patients.
The increased use of diagnostic tests has substantially
heightened awareness of infectious disease. However, there
continues to be a substantial need for reliable methods of
distinguishing colonization from infection, particularly in
the lower respiratory tract.
Despite efforts in most PICUs to develop antibiotic
policies, usage of antimicrobials is still not optimal.
Pressure of use of antibiotic exerts a powerful influence
on the microbiological status of the hospital generally and
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on the profile of PICU nosocomial infection in particular.
Modern day ICUs are spawning grounds for the so called
'Andromeda' strains of multiply resistant bacteria that are
now being encountered throughout the world (Crichton 1982).
Furthermore, it is concerning that Candida species seem to
be on the increase as pathogens - in this PICU Candida
accounts for 20% of infections. Future studies should aim
to define the factors governing superinfection by resistant
bacteria and Candida.
Finally, the most important infection control measure yet
the oldest and probably the cheapest - handwashing,
continues to be performed inconsistently by all health care
personnel and, sadly, the greatest offenders, in this
respect, are physicians. In terms of infection control, a
change in attitude towards this simple issue would result
in vast immediate benefits.
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APPENDIX 1
HOSPITAL FOR SICK CHILDREN, TORONTO
Infection Control Policies for Physicians and Surgeons
Hands must be washed for 15 seconds by the clock before and
after patient contacts (or between patient contacts if you
are touching charts, leaning on cribs etc. between
patients) or if going from a dirty area such as a wound to
a clean area such as the eyes. This will remove all
organisms transiently adhering to the skin.
(True emergencies are excepted of course).
CAREFUL THOROUGH HANDWASHING IS THE MOST IMPORTANT SINGLE
PROCEDURE IN PREVENTING THE SPREAD OF NOSOCOMIAL INFECTIONS
Dermatitis which predisposes to permanent carriage of
pathogens is to be prevented through the use of single use
packets of hand lotion. Multi-use bottles have been
identified as reservoirs of pathogens during epidemics.
Gowns are to be changed before and after contact with
patients in isolation. When removing gowns, if gloves are
not worn, carefully untie the ties and remove the gown by
the cuffs, causing a minimum of air disturbance. Wash
hands for 15 seconds. When removing gowns, if gloves are
worn, carefully untie the ties and remove the gown by the
cuffs, causing a minimum of air disturbance. Remove gloves
"rubber to rubber and skin to skin". Wash hands for 15
seconds. Patients with any symptoms of infection are to
be isolated promptly on identification of symptoms
compatible with diseases listed in the yellow pages of the
Infection Control Manual.
Skin Preparation for an invasive procedure - intravenous
infusion, arterial line, blood culture in any patient or
any procedure in an immunodeficient patient.
(1) if the skin is not clean, it must be cleaned
mechanically with isopropyl alcohol 70% by a doctor
or nurse who has just washed his or her hands.
(2) the appropriate antiseptic is chosen.
(3) after any dirt or blood on the skin has been removed
by cleansing, the appropriate antiseptic is applied
liberally, using friction, working from the centre of
the field to the periphery.
(4) the antiseptic must be allowed to dry for 30 seconds
(povidone-iodine) or 60 seconds (alcohol). No
antiseptic works immediately.
(5) if povidone-iodine has been used and allowed to dry
and the insertion site is to be palpated, the finger
doing the palpation must also undergo skin preparation
as in 4 above. (alternatively sterile gloves may be
worn).
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Skin Preparation for blood sampling other than blood
cultures
(1) the skin is cleaned with isopropyl alcohol 70%.
(2) the antiseptic is allowed to dry (30 to 60 seconds).
Note
Because there is usually no indwelling device and the
patient is not immunodeficient there is usually no need for
the more thorough skin preparation in such cases.
Prevention of Intravascular Infections (occult bacteraemia,
septic thrombophlebitis, cellulitis)
(a) IV cannulae should be used only when indicated and
discontinued when no longer indicated.
(b) Use measures aimed at preventing contamination of the
insertion site during insertion:-
thorough handwashing prior to insertion,
scrub site with antiseptic (Betadine) for 30-60
seconds,
secure cannula to stabilise it,
apply sterile dressing (gauze, bandaid, Tegederm,
Opsite) to skin catheter junction,
(c) Change intravenous catheters at 72 hours. Beyond this
time the risk of bacteraemia increases from 5% to 8%.
ALL INTRAVASCULAR LINES ARE DATED TO REMIND STAFF THAT THE
RISK OF ASSOCIATED INFECTION IS RELATED TO THE TIME LEFT IN
PLACE.
Urinary tract catheterisation
For short term use - 2 or 3 single catheterisations over 48
- 72 hours presents a lower infection risk than indwelling
catheterisation. Alternatives include condom drainage
(Texas catheter). See procedure on page 115 of the H.S.C.
Infection Control Manual which stresses the importance of
a closed, freely draining system opened only by personnel
familiar with this policy. (Wash hands, wear gloves,
cleanse perineum with iodophor, use lubricated catheter).
Remove as soon as possible.
Collection of blood for blood cultures
Wipe the diaphragm tops of the culture bottles with 70%
isopropyl alcohol and leave the alcohol wipe in place on
the blood culture bottle. If the skin is dirty, clean it
with 70% isopropyl alcohol and allow to dry. This removes
any dirt or blood on the skin that may interfere with
disinfection. See Skin Preparation (p 102) for details.
Swab the site with 10% povidone-iodine concentrically.
Allow to dry (about 60 seconds). Alternatively wear
sterile gloves. Change the needle on the syringe before
transferring the blood to the blood culture bottle. Blood
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cultures must be inoculated before any other collection
tubes. Pseudomonas fluorescens is a contaminant found in
coagulation study (citrate) tubes. If an additional skin
puncture is required, use a new needle. Dispose of all
discarded needles in a sharps container. Visitors are
screened for the presence of skin or respiratory
infections. Simple handwashing is sufficient and long
sleeved gowns are worn. A visitor should receive strict
instructions to handle only his or her child and not to
touch equipment or surfaces used for other patients.
Visitors under 12 are not permitted except in consultation
with the nurse in charge.
If you have an infection and must continue to work, please
observe the following:
If you have diarrhoea - wash hands very carefully after
using the bathroom and before touching patients or their
equipment. Try to avoid working with patients with
metabolic disease.
If you have a cold or any other respiratory infection, try
to avoid working when acutely ill, wear mask and gown for
any direct contact with patients (especially infants,
patients with congenital heart disease and immune
suppressed patients) and wash hands thoroughly before
touching patients and their equipment. 70% or more of
personnel with colds have the virus on their hands.
If you have a cold sore which is not completely dry you
should not work with neonates or with patients who have
burns, immuno-deficiency, blood dyscrasias or skin
disorders. If it is essential that you work cover the cold
sore with a mask or bandaid and wash hands thoroughly
before touching any patient. 60% or more of patients with
cold sores have the virus on their hands. If you have
herpetic whitlow (cold sore on the finger) you should not
have direct patient contact until the lesion is dry. If
you have a constant pain in one area, watch carefully to be
sure that shingles are not developing.
If you have any other infections, including abscesses or
boils please check with Occupational Health (daytime) or
Infectious Diseases (nights and weekends) before working.
If you are exposed to chickenpox and have never had
chickenpox, lived in the same house with or cared for
someone with chickenpox, please check with Occupational
Health to determine if and when you should go on leave of
absence. If you are exposed to measles please notfy
Occupational Health (daytime) or Infectious Diseases
(nights and weekends) before working.
If you are exposed to blood through contact with mucosa,
eye, or have massive skin contact, please consult
Occupational Health to assess the need for Hepatitis B
prophylaxis.
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If you are exposed to whooping cough, and develop a cough,
remind your doctor to consider that you may have whooping
cough. Reportable disease listed on p 90 of the HSC








site is cleaned with povidone iodine; sterile elastoplast
bandages are applied one under the catheter hub and one
over the insertion site.
central venous line
semipermeable dressing (Uniflex)) is used in normal
circumstances.
Gauze dressing is used when:-
frequent observation of the site is required,
the site and/or surrounding areas are infected,
a topical cream or ointment is prescribed,
the patient is diaphoretic and transparent
dressings are not sufficiently adhesive.
PERIPHERAL INTRAVENOUS INFUSIONS
Regular IV solutions
bag/syringe every 24 hours + prn + at
tubing change,




bag/syringe every 24 hours + prn + at
tube change,








bag/syringe every 24 hours + prn + at
tubing change,
TPN
bag/syringe every 24 hours + prn + at
tubing change,























every 7 days and prn,
every day if there is an
infection or if ointment is
prescribed, otherwise every
3 days.
every 24 hours + prn + at
tubing change,
every 48 hours includes T
piece,
every 24 hours + prn + at
tubing change,
every 72 hours includes T
piece,
every 72 hours,
every 7 days and prn,
every 24 hours and at tubing
change,
every 48 hours,
consider at day 10.
Dressing
on day 4 and every 3rd day thereafter or prn by nurse at
charge level. On catheter day 10 the site is evaulated by
the medical staff and consideration is given to changing
the tubing and catheter site.





every 24 hours +
tubing change,
every 48 hours,
consider at day 10.
prn at
BLOOD TUBING
blood product - every 6 hours,
tubing - every 24 hours (if blood in
tubing >6 hours old, flush
tubing through with new bag
hung),
(if blood warmer in use




Nursing care of post operative cardiac surgery patients:
incision, chest tube, pacing wires and transthoracic lines
in the post-op cardiovascular patient in ICU.
Note
Surgihesive ( Squibb) is a sterile waterproof bandage.






















assess dressing and change if not
intact or saturated with blood,
dressing is changed and op-site is
applied.
transfer to ward or on day 7
remove op-site and discontinue
dressing if clean and dry.
surgihesive
assess dressing and change if not
intact or saturated with blood,
dressing is changed and an
elastoplast dressing applied,
dressing change every 3 days.
no dressing.
dress after 1st post-op bath,
elastoplast applied,
dressing change,
dressing change every 3 days.
no dressing.
post bath clean exit site with a
betadine swab. Remove betadine
with sterile water,
clean exit sites as described
following each bath until removed.
Note
It is the responsibility of the bed side nurse to ensure
sterile scissors are available for chest tube removal.
Special Considerations
Follow the procedure for a sterile dressing change as
outlined in the HSC Nursing Procedure Manual. Remove
betadine with sterile water before applying your sterile
dressings. Use sterile scissors to cut elastoplast
dressings for chest tubes and pacing wires.
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APPENDIX 4
Care of Ventilated Patients
All patients are ventilated using either volume or pressure
limited ventilators, usually via a nasal endotracheal tube.
Endotracheal tubes are routinely suctioned hourly (more
frequently if required in invidual circumstances), using a
sterile, 'no touch' technique. Ventilator tubing is
changed every 3 days unless the endotracheal tube
secretions are heavily contaminated with a known pathogen,
in which case the tubing is changed daily.
Sterile water in humidifier circuits is changed daily.
APPENDIX 5
Nursing care procedure - prevention of nosocomial
conj unctivitis
Conjunctivitis is a common childhood illness that may range
from a mild self-limited infection to one that can destroy
vision and even cause death. Conjunctivitis caused by gram
negative enteric bacteria (usually P aeruginosa) may lead
to rapidly progressive and destructive ocular disease.
Other common pathogens that may lead to eye damage or
blindness are Haemophilus Influenzae, Strepthococcus
pneumoniae, Staphylococcus aureus, Branhamella Catarrhalis,
and Neisseria meningitides. The risk of contaminating the
cornea with nasopharyngeal secretions is directly related
to interventions such as intubation, tracheotomy care and
suctioning, administration of oxygen by hood or
administration of oxygen / air by croupette.
Usual Problems/Objectives/Timing
1 . Potential contamination of the cornea with
nasopharyngeal or endotracheal secretions.
a) Be aware of procedures / interventions that may put
the patient at risk for corneal contamination. For
example:
suctioning an ET tube or tracheotomy tube.
manipulation of a nasogastric tube.
use of an oxygen hood or croupette (where
condensation forms and moisture drops on the
patient's face).
colonization of pathogens.
b) Ensure that fluid and debris does not fall from
equipment onto the patient's face when suctioning or
administering tube feedings. Always withdraw the tube
away from (not over) the patient's face.
c) Cover the patient's eyes with a tissue when
suctioning.
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d) If necessary, enlist a second person to help restrain
the patient's head when carrying out procedures such
as suctioning.
e) Maintain an oxygen hood and croupette only for as long
as ordered.
2. Potential delay in identifying and treating
conj unctivitis.
a) Observe patient's eyes for redness and presence of
serous or purulent drainage.
b) If there is any redness or discharge from the eye(s),
send a swab for culture and sensitivities stat (prompt
identification of the causative organisms is
essential): simultaneously, notify the doctor and
obtain orders.
c) Document the condition of the eye and action taken in
the pateint's progress notes.
3. If conjunctivitis is diagnosed. Potential,
progressive and destructive ocular disease due to
incorrect management of procedures and poor hygiene.
a) Using sterile cotton swabs and sterile water, cleanse
the patient's eyes every 4 hours and p.r.n.
b) Record the condition of the patient's eyes before
cleansing, noting any drainage (amount and type), the
procedure and the condition of the eye afterwards.
c) Ensure that a freshly opened container of sterile
water is used for each procedure (do not leave
containers at the bedside).
d) Instruct the patient not to rub the eyes (arm
restraints may be necessary for an infant or young
child).
e) Explain to the family the importance of washing hands
before and after handling the child and not to use
washcloth or towel to wipe the eyes (some forms of
conjunctivitis are highly contagious).














Coarctation of aorta repair























Repair of total or
partial anomalous
venous drainage
Repair of sub¬
aortic stenosis
Repair of truncus
arteriosus
Mapping for WPW
syndrome
Norwood procedure
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